486 Mutations in HBV core18–27 immunodominant epitope evade viral control of cytotoxic t lymphocytes during combined antiviral treatment in tolerant children with chronic hepatitis B (Englisch)
- Neue Suche nach: Carey, I.
- Neue Suche nach: Cavers, M.
- Neue Suche nach: D'Antiga, L.
- Neue Suche nach: Longhi, M. S.
- Neue Suche nach: Ma, Y.
- Neue Suche nach: Bansal, S.
- Neue Suche nach: Byrne, J. A.
- Neue Suche nach: Mieli-Vergani, G.
- Neue Suche nach: Vergani, D.
- Neue Suche nach: Carey, I.
- Neue Suche nach: Cavers, M.
- Neue Suche nach: D'Antiga, L.
- Neue Suche nach: Longhi, M. S.
- Neue Suche nach: Ma, Y.
- Neue Suche nach: Bansal, S.
- Neue Suche nach: Byrne, J. A.
- Neue Suche nach: Mieli-Vergani, G.
- Neue Suche nach: Vergani, D.
In:
JOURNAL OF HEPATOLOGY
;
44
;
S181
;
2006
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:486 Mutations in HBV core18–27 immunodominant epitope evade viral control of cytotoxic t lymphocytes during combined antiviral treatment in tolerant children with chronic hepatitis B
-
Beteiligte:Carey, I. ( Autor:in ) / Cavers, M. ( Autor:in ) / D'Antiga, L. ( Autor:in ) / Longhi, M. S. ( Autor:in ) / Ma, Y. ( Autor:in ) / Bansal, S. ( Autor:in ) / Byrne, J. A. ( Autor:in ) / Mieli-Vergani, G. ( Autor:in ) / Vergani, D. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 44 ; S181
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2006
-
Format / Umfang:S181
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 44
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: Is adefovir dipivoxil the answer?Thio, C. L. et al. | 2006
- 4
-
Treating patients with HCV genotype 1 and low viraemia: More than meets the eyeCraxi, A. / Camma, C. et al. | 2006
- 8
-
Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipientsVarela, M. / Bruix, J. et al. | 2006
- 11
-
Fifth Forum on Liver TransplantationClavien, P. A. et al. | 2006
- 13
-
"Will all liver transplantation patients eventually die from cancer?"Sanchez, W. / Talwalkar, J. A. / Gores, G. J. et al. | 2006
- 19
-
Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?Aucejo, F. / Rofaiel, G. / Miller, C. et al. | 2006
- 23
-
What is the current treatment of PTLD after liver transplantation?Dufour, J. F. / Fey, M. F. et al. | 2006
- 27
-
Skin cancers after liver transplantation: What to do?Euvrard, S. / Kanitakis, J. et al. | 2006
- 32
-
Should we screen for colorectal cancer in liver transplantation?Delco, F. / Mullhaupt, B. et al. | 2006
- 39
-
Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in TaiwanLiu, C. J. / Lo, S. C. / Kao, J. H. / Tseng, P. T. / Lai, M. Y. / Ni, Y. H. / Yeh, S. H. / Chen, P. J. / Chen, D. S. et al. | 2006
- 47
-
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapyBrau, N. / Salvatore, M. / Rios-Bedoya, C. F. / Fernandez-Carbia, A. / Paronetto, F. / Rodriguez-Orengo, J. F. / Rodriguez-Torres, M. / for, t. P. et al. | 2006
- 56
-
Ophthalmologic side effects during alpha-interferon therapy for viral hepatitisdAlteroche, L. / Majzoub, S. / Lecuyer, A. I. / Delplace, M. P. / Bacq, Y. et al. | 2006
- 62
-
Safety and efficacy of adefovir dipivoxil in patients infectedwith lamivudine-resistant hepatitis B and HIV-1Benhamou, Y. / Thibault, V. / Vig, P. / Calvez, V. / Marcelin, A. G. / Fievet, M. H. / Currie, G. / Chang, C. G. / Biao, L. / Xiong, S. et al. | 2006
- 68
-
A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 casesYamada, H. / Ebara, M. / Yamaguchi, T. / Okabe, S. / Fukuda, H. / Yoshikawa, M. / Kishimoto, T. / Matsubara, H. / Hachiya, H. / Ishikura, H. et al. | 2006
- 76
-
Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapyChen, C. H. / Lee, C. M. / Lu, S. N. / Changchien, C. S. / Wang, J. C. / Wang, J. H. / Hung, C. H. / Hu, T. H. et al. | 2006
- 83
-
Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapseGerotto, M. / Dal Pero, F. / Bortoletto, G. / Ferrari, A. / Pistis, R. / Sebastiani, G. / Fagiuoli, S. / Realdon, S. / Alberti, A. et al. | 2006
- 88
-
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patientsMcHutchison, J. G. / Patel, K. / Pockros, P. / Nyberg, L. / Pianko, S. / Yu, R. Z. / Andrew Dorr, F. / Kwoh, T. J. et al. | 2006
- 97
-
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaZeuzem, S. / Buti, M. / Ferenci, P. / Sperl, J. / Horsmans, Y. / Cianciara, J. / Ibranyi, E. / Weiland, O. / Noviello, S. / Brass, C. et al. | 2006
- 104
-
Neuropsychological abnormalities in cirrhosis include learning impairmentOrtiz, M. / Cordoba, J. / Jacas, C. / Flavia, M. / Esteban, R. / Guardia, J. et al. | 2006
- 111
-
Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosisNagula, S. / Jain, D. / Groszmann, R. J. / Garcia-Tsao, G. et al. | 2006
- 118
-
Cadaveric full-size liver transplantation and the graft alternatives in adults: A comparative study from a single centreSebagh, M. / Yilmaz, F. / Karam, V. / Falissard, B. / Ichai, P. / Roche, B. / Castaing, D. / Guettier, C. / Samuel, D. / Azoulay, D. et al. | 2006
- 126
-
Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinomaLie-A-Ling, M. / Bakker, C. T. / Deurholt, T. / Hoekstra, R. / Wesseling, J. G. / Afford, S. C. / Bosma, P. J. et al. | 2006
- 134
-
Characterization of acute liver failure and development of a continuous risk of death staging system in childrenLiu, E. / MacKenzie, T. / Dobyns, E. L. / Parikh, C. R. / Karrer, F. M. / Narkewicz, M. R. / Sokol, R. J. et al. | 2006
- 142
-
Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinomaWada, A. / Fukui, K. / Sawai, Y. / Imanaka, K. / Kiso, S. / Tamura, S. / Shimomura, I. / Hayashi, N. et al. | 2006
- 151
-
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapySieghart, W. / Losert, D. / Strommer, S. / Cejka, D. / Schmid, K. / Rasoul-Rockenschaub, S. / Bodingbauer, M. / Crevenna, R. / Monia, B. P. / Peck-Radosavljevic, M. et al. | 2006
- 158
-
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based studyEl-Serag, H. B. / Siegel, A. B. / Davila, J. A. / Shaib, Y. H. / Cayton-Woody, M. / McBride, R. / McGlynn, K. A. et al. | 2006
- 167
-
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long termNeef, M. / Ledermann, M. / Saegesser, H. / Schneider, V. / Widmer, N. / Decosterd, L. A. / Rochat, B. / Reichen, J. et al. | 2006
- 176
-
Limited iron export by hepatocytes contributes to hepatic iron-loading in the Hfe knockout mouseChua, A. C. / Drake, S. F. / Herbison, C. E. / Olynyk, J. K. / Leedman, P. J. / Trinder, D. et al. | 2006
- 183
-
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranesVay, D. / Rigamonti, C. / Vidali, M. / Mottaran, E. / Alchera, E. / Occhino, G. / Sartori, M. / Albano, E. et al. | 2006
- 190
-
Hepatic steatosis and insulin resistance: Does etiology make a difference?Lonardo, A. / Lombardini, S. / Scaglioni, F. / Carulli, L. / Ricchi, M. / Ganazzi, D. / Adinolfi, L. E. / Ruggiero, G. / Carulli, N. / Loria, P. et al. | 2006
- 197
-
Non-alcoholic steatohepatitis: From cell biology to clinical practiceCortez-Pinto, H. / de Moura, M. C. / Day, C. P. et al. | 2006
- 209
-
Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesisLanger, D. A. / Shah, V. H. et al. | 2006
- 217
-
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesDAmico, G. / Garcia-Tsao, G. / Pagliaro, L. et al. | 2006
- 232
-
Canalicular membrane localization of hepatocyte aquaporin-8 is preserved in estradiol-17b-d-glucuronide-induced cholestasisMottino, A. D. / Carreras, F. I. / Gradilone, S. A. / Marinelli, R. A. / Vore, M. et al. | 2006
- 233
-
Induction of Angiopoietin-2 gene expression by COX-2: A novel role for COX-2 inhibitors during hepatocarcinogenesisTanaka, S. / Wands, J. R. / Arii, S. et al. | 2006
- 236
-
Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitisTakagi, H. / Hagiwara, S. / Hashizume, H. / Kanda, D. / Sato, K. / Sohara, N. / Kakizaki, S. / Takahashi, H. / Mori, M. / Kaneko, H. et al. | 2006
- 240
-
A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2Lam, C. W. / Cheung, K. M. / Tsui, M. S. / Yan, M. S. / Lee, C. Y. / Tong, S. F. et al. | 2006
- 243
-
Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicinEllis, E. / Wagner, M. / Lammert, F. / Nemeth, A. / Gumhold, J. / Strassburg, C. P. / Kylander, C. / Katsika, D. / Trauner, M. / Einarsson, C. et al. | 2006
- 246
-
Digestive endoscopy and HCV transmissionBronowicki, J. P. et al. | 2006
- 248
-
Announcements| 2006
- 249
-
Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm?Kloppel, G. / Kosmahl, M. et al. | 2006
- 251
-
Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: A foray across diagnostic boundariesCzaja, A. J. et al. | 2006
- 253
-
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?Larter, C. Z. / Farrell, G. C. et al. | 2006
- 262
-
Hepatitis C and hospital outcomes in patients admitted with alcohol-related problemsTsui, J. I. / Pletcher, M. J. / Vittinghoff, E. / Seal, K. / Gonzales, R. et al. | 2006
- 267
-
Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replicationTakehara, T. / Suzuki, T. / Ohkawa, K. / Hosui, A. / Jinushi, M. / Miyagi, T. / Tatsumi, T. / Kanazawa, Y. / Hayashi, N. et al. | 2006
- 275
-
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naive patients with chronic hepatitis C genotype 1 infectionFerenci, P. / Formann, E. / Laferl, H. / Gschwantler, M. / Hackl, F. / Brunner, H. / Hubmann, R. / Datz, C. / Stauber, R. / Steindl-Munda, P. et al. | 2006
- 283
-
Virologic response and resistance to adefovir in patients with chronic hepatitis BFung, S. K. / Chae, H. B. / Fontana, R. J. / Conjeevaram, H. / Marrero, J. / Oberhelman, K. / Hussain, M. / Lok, A. S. et al. | 2006
- 291
-
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot studyCornberg, M. / Hadem, J. / Herrmann, E. / Schuppert, F. / Schmidt, H. H. / Reiser, M. / Marschal, O. / Steffen, M. / Manns, M. P. / Wedemeyer, H. et al. | 2006
- 302
-
Significance of liver negative-strand HCV RNA quantitation in chronic hepatitis CYuki, N. / Matsumoto, S. / Tadokoro, K. / Mochizuki, K. / Kato, M. / Yamaguchi, T. et al. | 2006
- 310
-
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor respondersBerzigotti, A. / Rinaldi, M. F. / Magalotti, D. / Morelli, M. C. / Zappoli, P. / Andreone, P. / Rossi, C. / Zoli, M. et al. | 2006
- 317
-
Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigsLi, L. J. / Du, W. B. / Zhang, Y. M. / Li, J. / Pan, X. P. / Chen, J. J. / Cao, H. C. / Chen, Y. / Chen, Y. M. et al. | 2006
- 325
-
Hepatic gene induction in murine bone marrow after hepatectomyYamazaki, S. / Miki, K. / Takayama, T. / Hasegawa, K. / Sata, M. / Midorikawa, Y. / Aburatani, H. / Makuuchi, M. et al. | 2006
- 334
-
Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cellsDahlke, M. H. / Loi, R. / Warren, A. / Holz, L. / Popp, F. C. / Weiss, D. J. / Piso, P. / Bowen, D. G. / McCaughan, G. W. / Schlitt, H. J. et al. | 2006
- 342
-
Interferon-a enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cellsLiedtke, C. / Groger, N. / Manns, M. P. / Trautwein, C. et al. | 2006
- 350
-
Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasisZen, Y. / Sasaki, M. / Fujii, T. / Chen, T. C. / Chen, M. F. / Yeh, T. S. / Jan, Y. Y. / Huang, S. F. / Nimura, Y. / Nakanuma, Y. et al. | 2006
- 359
-
Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicityHanson, J. C. / Bostick, M. K. / Campe, C. B. / Kodali, P. / Lee, G. / Yan, J. / Maher, J. J. et al. | 2006
- 368
-
Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species contentPallottini, V. / Martini, C. / Bassi, A. M. / Romano, P. / Nanni, G. / Trentalance, A. et al. | 2006
- 375
-
Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in ratsHsu, M. K. / Qiao, L. / Ho, V. / Zhang, B. H. / Zhang, H. / Teoh, N. / Dent, P. / Farrell, G. C. et al. | 2006
- 383
-
Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient miceLorena, D. / Darby, I. A. / Gadeau, A. P. / Lam Shang Leen, L. / Rittling, S. / Porto, L. C. / Rosenbaum, J. / Desmouliere, A. et al. | 2006
- 391
-
Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytesTroadec, M. B. / Courselaud, B. / Detivaud, L. / Haziza-Pigeon, C. / Leroyer, P. / Brissot, P. / Loreal, O. et al. | 2006
- 400
-
Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndromeChazouilleres, O. / Wendum, D. / Serfaty, L. / Rosmorduc, O. / Poupon, R. et al. | 2006
- 407
-
Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemiaDe Bruyne, R. / Portmann, B. / Samyn, M. / Bansal, S. / Knisely, A. / Mieli-Vergani, G. / Dhawan, A. et al. | 2006
- 411
-
The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practiceMcHutchison, J. G. / Bartenschlager, R. / Patel, K. / Pawlotsky, J. M. et al. | 2006
- 422
-
Cellular and virological mechanisms of HBV drug resistanceLocarnini, S. / Mason, W. S. et al. | 2006
- 432
-
Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemiaBruchfeld, A. / Lindahl, K. / Stahle, L. / Schvarcz, R. et al. | 2006
- 433
-
ReplyMazzaro, C. / Rossi, P. / Pozzato, G. et al. | 2006
- 433
-
Effect of correcting transferrin saturation for body mass index in HFE C282Y homozygotesWaalen, J. / Beutler, E. et al. | 2006
- 436
-
Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied researchZeisel, M. B. / Baumert, T. F. et al. | 2006
- 441
-
The coming wave of HCV-related liver disease: Dilemmas and challengesPerz, J. F. / Alter, M. J. et al. | 2006
- 444
-
How to assess liver fibrosis and for what purpose?Beaugrand, M. et al. | 2006
- 446
-
Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanismWang, J. / Sun, R. / Wei, H. / Dong, Z. / Gao, B. / Tian, Z. et al. | 2006
- 455
-
Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infectionsDeuffic-Burban, S. / Mohamed, M. K. / Larouze, B. / Carrat, F. / Valleron, A. J. et al. | 2006
- 462
-
Performance of serum marker panels for liver fibrosis in chronic hepatitis CParkes, J. / Guha, I. N. / Roderick, P. / Rosenberg, W. et al. | 2006
- 475
-
Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infectionNisii, C. / Tempestilli, M. / Agrati, C. / Poccia, F. / Tocci, G. / Longo, M. A. / DOffizi, G. / Tersigni, R. / Lo Iacono, O. / Antonucci, G. et al. | 2006
- 484
-
Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)Maynard, M. / Pradat, P. / Bailly, F. / Rozier, F. / Nemoz, C. / Si Ahmed, S. N. / Adeleine, P. / Trepo, C. / a French Multicenter Group, a. et al. | 2006
- 491
-
Depression, anemia and health-related quality of life in chronic hepatitis CDan, A. A. / Martin, L. M. / Crone, C. / Ong, J. P. / Farmer, D. W. / Wise, T. / Robbins, S. C. / Younossi, Z. M. et al. | 2006
- 499
-
Place of residence and distance to medical care influence the diagnosis of hepatitis C: A population-based studyMonnet, E. / Collin-Naudet, E. / Bresson-Hadni, S. / Minello, A. / Di Martino, V. / Carel, D. / Jooste, V. / Gagnaire, A. / Evrard, P. / Obert-Clerc, B. et al. | 2006
- 507
-
The effect of pegylated interferon-a on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infectionLeemans, W. F. / Flink, H. J. / Janssen, H. L. / Niesters, H. G. / Schalm, S. W. / de Man, R. A. et al. | 2006
- 512
-
Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertensionWiest, R. / Jurzik, L. / Moleda, L. / Froh, M. / Schnabl, B. / Horsten, S. v. / Scholmerich, J. / Straub, R. H. et al. | 2006
- 520
-
Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centresMentha, G. / Giostra, E. / Majno, P. E. / Bechstein, W. O. / Neuhaus, P. / OGrady, J. / Praseedom, R. K. / Burroughs, A. K. / Treut, Y. P. / Kirkegaard, P. et al. | 2006
- 529
-
Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activationElinav, E. / Abd-Elnabi, A. / Pappo, O. / Bernstein, I. / Klein, A. / Engelhardt, D. / Rabbani, E. / Ilan, Y. et al. | 2006
- 537
-
Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in miceWolf, A. M. / Wolf, D. / Avila, M. A. / Moschen, A. R. / Berasain, C. / Enrich, B. / Rumpold, H. / Tilg, H. et al. | 2006
- 544
-
Regulatory effects of tumor necrosis factor-alpha and interleukin-6 on HAMP expression in iron loaded rat hepatocytesDzikaite, V. / Holmstrom, P. / Stal, P. / Eckes, K. / Hagen, K. / Eggertsen, G. / Gafvels, M. / Melefors, O. / Hultcrantz, R. et al. | 2006
- 552
-
Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 responseCabillic, F. / Rougier, N. / Basset, C. / Lecouillard, I. / Quelvennec, E. / Toujas, L. / Guguen-Guillouzo, C. / Corlu, A. et al. | 2006
- 560
-
Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systemsAdrian, J. E. / Poelstra, K. / Scherphof, G. L. / Molema, G. / Meijer, D. K. / Reker-Smit, C. / Morselt, H. W. / Kamps, J. A. et al. | 2006
- 568
-
Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in ratsNamisaki, T. / Yoshiji, H. / Kojima, H. / Yoshii, J. / Ikenaka, Y. / Noguchi, R. / Sakurai, S. / Yanase, K. / Kitade, M. / Yamazaki, M. et al. | 2006
- 576
-
Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damageSlotta, J. E. / Scheuer, C. / Menger, M. D. / Vollmar, B. et al. | 2006
- 586
-
Mice heterozygous for the Mdr2 gene demonstrate decreased PEMT activity and diminished steatohepatitis on the MCD dietIgolnikov, A. C. / Green, R. M. et al. | 2006
- 593
-
HBV drug resistance: Mechanisms, detection and interpretationShaw, T. / Bartholomeusz, A. / Locarnini, S. et al. | 2006
- 607
-
The culture of designing hepato-biliary randomised trialsGluud, C. et al. | 2006
- 616
-
Acute hepatitis associated with the use of green tea infusionsJimenez-Saenz, M. / Martinez-Sanchez, M. d. et al. | 2006
- 617
-
Occult hepatitis B virus infection and transfusionAllain, J. P. et al. | 2006
- 620
-
Risk scores in cirrhotic patients: From non-transplant surgery to transplantation and backDurand, F. et al. | 2006
- 623
-
EASL: A growing association in the global worldPawlotsky, J. M. / EASL, S. S. et al. | 2006
- 624
-
HCV therapy in 2006: Down with ALT levels, in with awareness of co-existent metabolic syndromeHarrison, S. A. et al. | 2006
- 627
-
Immunosuppression and outcomes of patients transplanted for hepatitis CLake, J. R. et al. | 2006
- 630
-
Staging systems for hepatocellular carcinoma: Should we all use the BCLC system?Marrero, J. A. et al. | 2006
- 633
-
Steroids or cocktails for alcoholic hepatitisOShea, R. / McCullough, A. J. et al. | 2006
- 637
-
Sixth Forum on Liver Transplantation. Center approach to liver diseases. Is it worthwhile?Clavien, P. A. et al. | 2006
- 639
-
Do we need a center approach to treat patients with liver diseases?Clavien, P. A. / Mullhaupt, B. / Pestalozzi, B. C. et al. | 2006
- 642
-
Does a liver center make sense from a cost perspective?Delco, F. / Muller, M. J. et al. | 2006
- 647
-
Who should perform liver transplantation? Should that be the transplant surgeon, the hepatobilary surgeon, or the general surgeon?Desai, D. M. / Kuo, P. C. et al. | 2006
- 649
-
Part II: The Hepatobiliary SurgeonBelghiti, J. et al. | 2006
- 652
-
Part III: The General SurgeonSenninger, N. et al. | 2006
- 655
-
Who should treat liver transplant patients? The transplant hepatologist or the gastroenterologist? Part I: The Transplant HepatologistGaglio, P. J. / Brown, R. S. et al. | 2006
- 657
-
Part II: The GastroenterologistMartin, P. et al. | 2006
- 659
-
What impact does a specialized center for transplantation and heptobiliary disease have on post-graduate resident training of gastroenterologists and surgeons?Tuttle-Newhall, J. E. / Diehl, A. M. et al. | 2006
- 663
-
Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cellsRen, X. / Luo, G. / Xie, Z. / Zhou, L. / Kong, X. / Xu, A. et al. | 2006
- 671
-
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsBain, V. G. / Kaita, K. D. / Yoshida, E. M. / Swain, M. G. / Heathcote, E. J. / Neumann, A. U. / Fiscella, M. / Yu, R. / Osborn, B. L. / Cronin, P. W. et al. | 2006
- 679
-
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CPrati, D. / Shiffman, M. L. / Diago, M. / Gane, E. / Rajender Reddy, K. / Pockros, P. / Farci, P. / OBrien, C. B. / Lardelli, P. / Blotner, S. et al. | 2006
- 686
-
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis CSebastiani, G. / Vario, A. / Guido, M. / Noventa, F. / Plebani, M. / Pistis, R. / Ferrari, A. / Alberti, A. et al. | 2006
- 694
-
Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosisSelzner, N. / Selzner, M. / Jochum, W. / Amann-Vesti, B. / Graf, R. / Clavien, P. A. et al. | 2006
- 702
-
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrenceTisone, G. / Orlando, G. / Cardillo, A. / Palmieri, G. / Manzia, T. M. / Baiocchi, L. / Lionetti, R. / Anselmo, A. / Toti, L. / Angelico, M. et al. | 2006
- 710
-
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized studyLlado, L. / Xiol, X. / Figueras, J. / Ramos, E. / Memba, R. / Serrano, T. / Torras, J. / Garcia-Gil, A. / Gonzalez-Pinto, I. / Castellote, J. et al. | 2006
- 717
-
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppressionBerenguer, M. / Aguilera, V. / Prieto, M. / San Juan, F. / Rayon, J. M. / Benlloch, S. / Berenguer, J. et al. | 2006
- 723
-
Prospective validation of the Barcelona Clinic Liver Cancer staging systemCillo, U. / Vitale, A. / Grigoletto, F. / Farinati, F. / Brolese, A. / Zanus, G. / Neri, D. / Boccagni, P. / Srsen, N. / DAmico, F. et al. | 2006
- 732
-
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibratesShiri-Sverdlov, R. / Wouters, K. / Gorp, P. J. / Gijbels, M. J. / Noel, B. / Buffat, L. / Staels, B. / Maeda, N. / Bilsen, M. v. / Hofker, M. H. et al. | 2006
- 742
-
Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured ratsOyagi, S. / Hirose, M. / Kojima, M. / Okuyama, M. / Kawase, M. / Nakamura, T. / Ohgushi, H. / Yagi, K. et al. | 2006
- 749
-
Growth and differentiation of colony-forming human hepatocytes in vitroYamasaki, C. / Tateno, C. / Aratani, A. / Ohnishi, C. / Katayama, S. / Kohashi, T. / Hino, H. / Marusawa, H. / Asahara, T. / Yoshizato, K. et al. | 2006
- 758
-
Eve-3: A liver enriched suppressor of Ras/MAPK signalingKing, J. A. / Corcoran, N. M. / DAbaco, G. M. / Straffon, A. F. / Smith, C. T. / Poon, C. L. / Buchert, M. / I, S. / Hall, N. E. / Lock, P. et al. | 2006
- 768
-
Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronidesZelcer, N. / Wetering, K. v. / Waart, R. d. / Scheffer, G. L. / Marschall, H. U. / Wielinga, P. R. / Kuil, A. / Kunne, C. / Smith, A. / Valk, M. v. et al. | 2006
- 776
-
Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measureNewton, J. L. / Bhala, N. / Burt, J. / Jones, D. E. et al. | 2006
- 784
-
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-A randomised clinical trialPhillips, M. / Curtis, H. / Portmann, B. / Donaldson, N. / Bomford, A. / OGrady, J. et al. | 2006
- 791
-
Clinical characteristics and prognostic markers in disulfiram-induced liver injuryBjornsson, E. / Nordlinder, H. / Olsson, R. et al. | 2006
- 798
-
Molecular prognostication of liver cancer: End of the beginningThorgeirsson, S. S. / Lee, J. S. / Grisham, J. W. et al. | 2006
- 806
-
Ischemic cholangiopathyDeltenre, P. / Valla, D. C. et al. | 2006
- 818
-
Occult HBV infection and blood transfusionPrati, D. / Gerosa, A. / Porretti, L. et al. | 2006
- 819
-
In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases?Verma, S. et al. | 2006
- 821
-
6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: Dose or level dependent?Derijks, L. J. / Gilissen, L. P. / de Boer, N. K. / Mulder, C. J. et al. | 2006
- 822
-
Length versus width in liver biopsiesCholongitas, E. / Quaglia, A. / Dhillon, A. P. / Patch, D. / Burroughs, A. K. et al. | 2006
- 823
-
Clinical practice and ideal liver biopsy sampling standards:Not just a matter of centimetersGuido, M. / Colloredo, G. / Fassan, M. / Rugge, M. et al. | 2006
- 825
-
The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaRumi, M. G. / DAmbrosio, R. / Aghemo, A. et al. | 2006
- 827
-
Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patientsRomero-Gomez, M. / Otero, M. c. / Sanchez-Munoz, D. / Ramirez-Arcos, M. / Larraona, J. L. / Suarez Garcia, E. / Vargas-Romero, J. et al. | 2006
- 829
-
Liver transplantation in an adult with sclerosing cholangitis due to Langerhans cell histiocytosisGriffiths, W. / Davies, S. / Gibbs, P. / Thillainayagam, A. / Alexander, G. et al. | 2006
- 832
-
Angiopoietin-like proteins: Another player in the metabolic fieldGeorge, J. et al. | 2006
- 835
-
Corrigendum to "Resistance to adefovir: A new challenge in the treatment of chronic hepatitis B" [J Hepatol 43 (2005) 920-923]Marcellin, P. / Asselah, T. et al. | 2006
- 837
-
Lets assume that hepatitis C reduces the cardiovascular risk in dialysis patients: Are there practical implications?Cattaneo, D. / Perico, N. / Remuzzi, G. et al. | 2006
- 839
-
The paradox of Epstein-Barr virus-associated hepatitisNegro, F. et al. | 2006
- 842
-
Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytesSchorr, O. / Borel, C. / Trepo, C. / Zoulim, F. / Hantz, O. et al. | 2006
- 848
-
Alterations of leptin during IFN-a therapy in patients with chronic viral hepatitisZografos, T. A. / Rigopoulou, E. I. / Liaskos, C. / Togousidis, E. / Zachou, K. / Gatselis, N. / Germenis, A. / Dalekos, G. N. et al. | 2006
- 856
-
Association between vitamin D receptor, CCR5, TNF-a and TNF-b gene polymorphisms and HBV infection and severity of liver diseaseSuneetha, P. V. / Sarin, S. K. / Goyal, A. / Kumar, G. T. / Shukla, D. K. / Hissar, S. et al. | 2006
- 864
-
Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysisButt, A. A. / Evans, R. / Skanderson, M. / Shakil, A. O. et al. | 2006
- 869
-
Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cellsNaka, K. / Abe, K. i. / Takemoto, K. / Dansako, H. / Ikeda, M. / Shimotohno, K. / Kato, N. et al. | 2006
- 879
-
The role of Epstein-Barr virus in acute and chronic hepatitisDrebber, U. / Kasper, H. U. / Krupacz, J. / Haferkamp, K. / Kern, M. A. / Steffen, H. M. / Quasdorff, M. / zur Hausen, A. / Odenthal, M. / Dienes, H. P. et al. | 2006
- 886
-
Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat liversLoureiro-Silva, M. R. / Iwakiri, Y. / Abraldes, J. G. / Haq, O. / Groszmann, R. J. et al. | 2006
- 894
-
Role of pH in protection by low sodium against hypoxic injury in isolated perfused rat liversVairetti, M. / Richelmi, P. / Berte, F. / Currin, R. T. / Lemasters, J. J. / Imberti, R. et al. | 2006
- 902
-
Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablationPacella, C. M. / Bizzarri, G. / Francica, G. / Forlini, G. / Petrolati, A. / Valle, D. / Anelli, V. / Bianchini, A. / Nuntis, S. D. / Pacella, S. et al. | 2006
- 910
-
Cryopreservation of hepatic stellate cellsNeyzen, S. / Van de Leur, E. / Borkham-Kamphorst, E. / Herrmann, J. / Hollweg, G. / Gressner, A. M. / Weiskirchen, R. et al. | 2006
- 918
-
Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: Involvement of JNK and ERK MAP kinasesConde de la Rosa, L. / Schoemaker, M. H. / Vrenken, T. E. / Buist-Homan, M. / Havinga, R. / Jansen, P. L. / Moshage, H. et al. | 2006
- 930
-
Pyruvate ameliorates the defect in ureogenesis from ammonia in citrin-deficient miceMoriyama, M. / Li, M. X. / Kobayashi, K. / Sinasac, D. S. / Kannan, Y. / Iijima, M. / Horiuchi, M. / Tsui, L. C. / Tanaka, M. / Nakamura, Y. et al. | 2006
- 939
-
Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotidesMartin-Armas, M. / Simon-Santamaria, J. / Pettersen, I. / Moens, U. / Smedsrod, B. / Sveinbjornsson, B. et al. | 2006
- 947
-
The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regenerationvan den Heuvel, M. C. / Gouw, A. S. / Boot, M. / Slooff, M. J. / Poppema, S. / de Jong, K. P. et al. | 2006
- 956
-
Metabolic profiling of livers and blood from obese Zucker ratsSerkova, N. J. / Jackman, M. / Brown, J. L. / Liu, T. / Hirose, R. / Roberts, J. P. / Maher, J. J. / Niemann, C. U. et al. | 2006
- 963
-
Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cellsKannarkat, G. T. / Tuma, D. J. / Tuma, P. L. et al. | 2006
- 971
-
Aspartyl-(asparaginyl)-b-hydroxylase regulates hepatocellular carcinoma invasivenessMonte, S. M. / Tamaki, S. / Cantarini, M. C. / Ince, N. / Wiedmann, M. / Carter, J. J. / Lahousse, S. A. / Califano, S. / Maeda, T. / Ueno, T. et al. | 2006
- 984
-
The role of apoptosis versus oncotic necrosis in liver injury: Facts or faith?Schulze-Bergkamen, H. / Schuchmann, M. / Fleischer, B. / Galle, P. R. et al. | 2006
- 994
-
Cardiac electrophysiological abnormalities in patients with cirrhosisZambruni, A. / Trevisani, F. / Caraceni, P. / Bernardi, M. et al. | 2006
- 1003
-
Transferrin saturation should not be corrected for body mass index in screening studies for haemochromatosisThorstensen, K. / Asberg, A. et al. | 2006
- 1005
-
Primary sclerosing cholangitis can present with acute liver failure: Report of two casesBergquist, A. / Glaumann, H. / Lindberg, B. / Broome, U. et al. | 2006
- 1009
-
Fighting viral hepatitis with small RNAsWill, H. / Grundhoff, A. et al. | 2006
- 1013
-
Risk factors for hepatocellular carcinoma in HCV-cirrhosis: What we know and what is missingFattovich, G. / Llovet, J. M. et al. | 2006
- 1017
-
Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cellsGonzalez-Carmona, M. A. / Schussler, S. / Serwe, M. / Alt, M. / Ludwig, J. / Sproat, B. S. / Steigerwald, R. / Hoffmann, P. / Quasdorff, M. / Schildgen, O. et al. | 2006
- 1026
-
Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infectionGaslightwala, I. / Bini, E. J. et al. | 2006
- 1033
-
Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive ratsAngermayr, B. / Mejias, M. / Gracia-Sancho, J. / Garcia-Pagan, J. C. / Bosch, J. / Fernandez, M. et al. | 2006
- 1040
-
Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertensionAndreu, V. / Garcia-Pagan, J. C. / Lionetti, R. / Piera, C. / Abraldes, J. G. / Bosch, J. et al. | 2006
- 1046
-
In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: A comparative study to HGFKhai, N. C. / Takahashi, T. / Ushikoshi, H. / Nagano, S. / Yuge, K. / Esaki, M. / Kawai, T. / Goto, K. / Murofushi, Y. / Fujiwara, T. et al. | 2006
- 1055
-
Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytesMeng, F. / Yamagiwa, Y. / Ueno, Y. / Patel, T. et al. | 2006
- 1066
-
Cholangiocarcinoma and Clonorchis sinensis infection: A case-control study in KoreaChoi, D. / Lim, J. H. / Lee, K. T. / Lee, J. K. / Choi, S. H. / Heo, J. S. / Jang, K. T. / Lee, N. Y. / Kim, S. / Hong, S. T. et al. | 2006
- 1074
-
A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteinsNishikawa, T. / Nakajima, T. / Moriguchi, M. / Jo, M. / Sekoguchi, S. / Ishii, M. / Takashima, H. / Katagishi, T. / Kimura, H. / Minami, M. et al. | 2006
- 1083
-
Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failureChatauret, N. / Desjardins, P. / Zwingmann, C. / Rose, C. / Rao, K. V. / Butterworth, R. F. et al. | 2006
- 1089
-
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohortsIkeda, K. / Arase, Y. / Saitoh, S. / Kobayashi, M. / Someya, T. / Hosaka, T. / Akuta, N. / Suzuki, Y. / Suzuki, F. / Sezaki, H. et al. | 2006
- 1098
-
Hepatic stellate cells do not derive from the neural crestCassiman, D. / Barlow, A. / Vander Borght, S. / Libbrecht, L. / Pachnis, V. et al. | 2006
- 1105
-
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure miceNguyen, J. H. / Yamamoto, S. / Steers, J. / Sevlever, D. / Lin, W. / Shimojima, N. / Castanedes-Casey, M. / Genco, P. / Golde, T. / Richelson, E. et al. | 2006
- 1115
-
The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitroKoenig, S. / Krause, P. / Drabent, B. / Schaeffner, I. / Christ, B. / Schwartz, P. / Unthan-Fechner, K. / Probst, I. et al. | 2006
- 1125
-
Hepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytesAndriopoulos, B. / Pantopoulos, K. et al. | 2006
- 1132
-
Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host diseaseSato, T. / Habtezion, A. / Beilhack, A. / Schulz, S. / Butcher, E. / Thorlacius, H. et al. | 2006
- 1141
-
Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediatedNelson, L. / Vergnolle, N. / DMello, C. / Chapman, K. / Le, T. / Swain, M. G. et al. | 2006
- 1150
-
Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancyVallejo, M. / Briz, O. / Serrano, M. A. / Monte, M. J. / Marin, J. J. et al. | 2006
- 1158
-
Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated ratsSvegliati-Baroni, G. / Ghiselli, R. / Marzioni, M. / Alvaro, D. / Mocchegiani, F. / Saccomanno, S. / Sisti, V. / Ugili, L. / Orlando, F. / Alpini, G. et al. | 2006
- 1167
-
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2Haukeland, J. W. / Damas, J. K. / Konopski, Z. / Loberg, E. M. / Haaland, T. / Goverud, I. / Torjesen, P. A. / Birkeland, K. / Bjoro, K. / Aukrust, P. et al. | 2006
- 1175
-
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver diseaseThabut, D. / Naveau, S. / Charlotte, F. / Massard, J. / Ratziu, V. / Imbert-Bismut, F. / Cazals-Hatem, D. / Abella, A. / Messous, D. / Beuzen, F. et al. | 2006
- 1186
-
From viral pathobiology to the treatment of hepatitis B virus infection EASL Monothematic Conference (Istanbul, Turkey, October 6-8, 2005)Craxi, A. / Yurdaydn, C. et al. | 2006
- 1196
-
`Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesisLonardo, A. / Carani, C. / Carulli, N. / Loria, P. et al. | 2006
- 1208
-
Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasisBihl, F. / Emmenegger, U. / Reichen, J. / Neftel, K. A. / Zimmermann, A. / Cerny, A. et al. | 2006
- 1213
-
The expanding role of the bile acid receptor FXR in the small intestineCariou, B. / Staels, B. et al. | 2006
- I
-
Guide for Authors| 2006
- III
-
Volume Contents| 2006
- S2
-
Therapeutic management of hepatitis and HIV infection in co-infected patients: Results of a survey performed before the 2005 Consensus ConferenceSalmon, D. / Robain, M. / Rockstroh, J. K. / Benhamou, Y. et al. | 2006
- S6
-
10 Directed evolution of novel gene shuffled interferon alphas for the treatment of hepatitis CBrideau-Andersen, A. / Huang, X. / Chang Sun, S. / Chen, T. / Stark, D. / Sas, I. / Dawes, G. / Zadik, L. / Guptill, D. / Yang, S. et al. | 2006
- S6
-
Epidemiology of viral hepatitis and HIV co-infectionAlter, M. J. et al. | 2006
- S8
-
15 Redistribution of intrahepatic NKT regulatory lymphocytes via administration of beta glycolipids: A possible role for the liver in the alleviation of immune-mediated disordersLalazar, G. / Preston, S. / Eliakim, N. / Pappo, O. / Zolotarov, L. / Ilan, Y. et al. | 2006
- S10
-
Virology of hepatitis B and C viruses and antiviral targetsPawlotsky, J. M. et al. | 2006
- S11
-
23 Nadolol+Isosorbide-5-mononitrate (NAD+ISMN) vs NAD+ISMN + endoscopic band ligation in the prevention of rebleeding in patients with cirrhosis. Preliminary results of a multicenter RCTGarcia-Pagan, J. C. / Villanueva, C. / Albillos, A. / Bañ / ares, R. / Planas, R. / Casado, M. / Bosch, J. et al. | 2006
- S12
-
26 Expression profiling and CGH array as prognostic tools in hepatoblastomaArmengol, C. / Cairo, S. / Fabre, M. / Renard, C. A. / Buendia, M. A. et al. | 2006
- S14
-
Influence of HIV co-infection on hepatitis C immunopathogenesisKoziel, M. J. et al. | 2006
- S14
-
31 Hepatitis B virus infection is dependent on a multistep attachment and entry process mediated by the preS1 and the S-domainGlebe, D. / Gruen, S. / Bulavaite, A. / Sasnauskas, K. / Gerlich, W. H. et al. | 2006
- S15
-
34 Detectable HBV-specific T cell responses in liver transplant recipients: A comparison to chronic hepatitis BLoggi, E. / Bihl, F. K. / Chisholm, J. V. / Testa, L. / Cursaro, C. / Biselli, M. / Pinna, A. D. / Bernardi, M. / Brander, C. / Andreone, P. et al. | 2006
- S16
-
37 Gene therapy of chronic hepatitis B infection using a high-capacity adenovirus expressing interleukin 12 under the control of a liver specific mifepristone-inducible promoterCrettaz, J. / Ochoa, L. / Pañ / eda, A. / Olagü / e, C. / Vales, A. / Kochanek, S. / Prieto, J. / Gonzalez-Aseguinolaza, G. et al. | 2006
- S19
-
Natural history and predictors of disease severity in chronic hepatitis CMassard, J. / Ratziu, V. / Thabut, D. / Moussalli, J. / Lebray, P. / Benhamou, Y. / Poynard, T. et al. | 2006
- S20
-
43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis BZhao, H. / Si, C. W. / Wei, L. / Wan, M. B. / Ying, Y. K. / Hou, J. L. / Niu, J. Q. / Wang, G. Q. / Masashi, M. et al. | 2006
- S21
-
45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027)Shouval, D. / Akarca, U. S. / Hatzis, G. / Kitis, G. / Lai, C. L. / Cheinquer, H. / Chang, T. T. / Zink, R. / Zhu, J. / Brett-Smith, H. et al. | 2006
- S23
-
50 Durability of response and occurrence of late response to peginterferon alpha-2a (40KD) [PEGASYS] one year post-treatment in patients with HBeAg-positive chronic hepatitis BLau, G. K. / Piratvisuth, T. / Luo, K. X. / Marcellin, P. / Thongsawat, S. / Cooksley, G. / Gane, E. / Fried, M. W. / Popescu, M. / Wu, J. et al. | 2006
- S24
-
52 A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysisChan, H. L. / Lai, C. L. / Cho, M. / Heathcote, J. / Moon, Y. M. / Chao, Y. C. / Myers, R. / Minuk, G. / Marcellin, P. / Jeffers, L. et al. | 2006
- S25
-
Influence of viral hepatitis on HIV infectionRockstroh, J. K. et al. | 2006
- S27
-
60 Analysis of HBV-specific T-cell responses in patients with occult HBV infectionZerbini, A. / Pilli, M. / Boni, C. / Fisicaro, P. / Penna, A. / Laccabue, D. / Di Vincenzo, P. / Giuberti, T. / Raffa, G. / Pollicino, T. et al. | 2006
- S28
-
63 Hepatic expression of the forkhead transcription factor foxO1 is increased in non-alcoholic steatohepatitis and associated with gluconeogenesis and insulin resistanceValenti, L. / Rametta, R. / Fracanzani, A. L. / Dongiovanni, P. / Fargion, S. et al. | 2006
- S28
-
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infectionVallet-Pichard, A. / Pol, S. et al. | 2006
- S30
-
68 Long-term low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in bile duct-ligated rats with advanced liver fibrosisNeef, M. / Ledermann, M. / Saegesser, H. / Schneider, V. / Reichen, J. et al. | 2006
- S31
-
71 The oncolytic adenovirus ADP53DPR replicates selectively in p53 altered tumor cells and potential tumor spectrum is not limited by the p73 statusKuehnel, F. / Wirth, T. C. / Zender, L. / Manns, M. P. / Kubicka, S. et al. | 2006
- S35
-
HCV virological assessmentForns, X. / Costa, J. et al. | 2006
- S37
-
84 P75 neurotrophin receptor promotes liver regeneration via regulation of hepatic stellate cell differentiationPassino, M. A. / Sikorski, S. L. / Akassoglou, K. et al. | 2006
- S39
-
89 Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease: A case control studyFracanzani, A. L. / Burdick, L. / Rasselli, S. / Pedotti, P. / Grigore, L. / Santorelli, G. / Valenti, L. / Maraschi, A. / Catapano, A. / Fargion, S. et al. | 2006
- S40
-
Options for treatment of hepatitis C in HIV-infected personsThomas, D. L. et al. | 2006
- S40
-
91 Survival and causes of death in patients with elevated liver enzymes associated with non-alcoholic fatty liver disease (NAFLD)Ekstedt, M. / Franzé / n, L. E. / Mathiesen, U. L. / Holmqvist, M. / Bodemar, G. / Kechagias, S. et al. | 2006
- S42
-
96 Estrogens and IGF1 promote the proliferation of hepatic cyst epithelium in autosomal dominant polycystic kidney disease (ADPKD)Torrice, A. / Alvaro, D. / Onori, P. / Franchitto, A. / Mancino, M. G. / Alpini, G. / Jefferson, D. M. / Angelico, M. / Strazzabosco, M. / Attili, A. F. et al. | 2006
- S43
-
99 Expression of cytoprotective genes in livers and hepatocellular carcinomas, and contribution of heme oxygenase 1 to drug resistanceSass, G. / Ocker, M. / Leukel, P. / Hashemolhosseini, S. / Tiegs, G. et al. | 2006
- S44
-
Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidatesSoriano, V. et al. | 2006
- S45
-
104 Cardiotrophin-1 is an essential factor in the natural defense of the liver against fas-induced cell deathMarqué / s, J. M. / Prieto, J. / Bustos, M. et al. | 2006
- S46
-
107 Transplantation of endothelial progenitor cells improves carbon tetrachloride (CCL4)-induced liver cirrhosis in ratsNakamura, T. / Torimura, T. / Sakamoto, M. / Taniguchi, E. / Hashimoto, O. / Inoue, K. / Sakata, R. / Ueno, T. / Sata, M. et al. | 2006
- S49
-
Treatment algorithm for the management of hepatitis C in HIV-coinfected personsSulkowski, M. S. et al. | 2006
- S53
-
118 Alginate-encapsulated HEPG2 cells in a pilot-scale fluidised bed bioreactor maintain performance in human liver failure plasma making them suitable for use in a bioartificial liverCoward, S. M. / Legallais, C. / Thomas, M. / Tofteng, F. / Larsen, F. / Hodgson, H. J. / Selden, C. et al. | 2006
- S56
-
127 Liver transplantation for HCV-alcohol aetiology: Is the outcome similar to those to HCV or alcohol alone?Aguilera, V. / Berenguer, M. / Benlloch, S. / Prieto, M. / Berenguer, J. et al. | 2006
- S56
-
Assessment of efficacy of treatment in HCV: Infection and diseaseChung, R. T. et al. | 2006
- S57
-
130 Applicability and safety of extracorporeal liver support using albumin dialysis (MARS) in the setting of liver transplantationCatalina, M. V. / Ripoll, C. / Clemente, G. / Salcedo, M. / Rincon, D. / Matilla, A. / Nuñ / ez, O. / Beceiro, I. / Lo Iacono, O. et al. | 2006
- S58
-
133 Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progressionCholongitas, E. / Quaglia, A. / Samonakis, D. / Papatheodoridis, G. V. / Senzolo, M. / Triantos, C. / Patch, D. / Dhillon, A. P. / Burroughs, A. K. et al. | 2006
- S60
-
Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patientsButi, M. / Wong, J. / Casado, M. A. / Esteban, R. et al. | 2006
- S61
-
142 Prognostic value of actin-free GC-globulin in children with acute liver failureHind, J. / Hussain, M. J. / Cheeseman, P. / Dhawan, A. / Vergani, D. / Mieli-Vergan, G. et al. | 2006
- S62
-
145 Budd-Chiari syndrome (BCS): The Edinburgh experienceKochar, N. / Griffin, S. P. / Ferguson, J. W. / Redhead, D. N. / Finlayson, N. D. / Hayes, P. C. et al. | 2006
- S63
-
148 Clinical features and outcome of hepatic failure associated with Epstein-Barr virus infectionLim, Y. S. / Kim, D. K. / Kim, K. M. / Lee, H. C. / Chung, Y. H. / Lee, Y. S. / Suh, D. J. et al. | 2006
- S64
-
151 Transplantation of HBsAg-positive livers: A suitable option for all HBV positive recipients? A single center experienceMontalbano, M. / De Caro, G. / Volpes, R. / Minervini, M. I. / Gridelli, B. et al. | 2006
- S65
-
Natural history of chronic hepatitis B in co-infected patientsPuoti, M. / Torti, C. / Bruno, R. / Filice, G. / Carosi, G. et al. | 2006
- S67
-
159 Introduction and persistence of type III hepatitis a strain in FranceMackiewicz, V. / Roque-Afonso, A. M. / Cotterel, B. / Lebraud, P. / Santa-Ollala, P. / Delarocque-Astagneau, E. / Dussaix, E. et al. | 2006
- S68
-
162 HIV infected patients listed for liver transplantation have shorter intention-to-treat survival than non-infected patientsSanz, C. / Salcedo, M. / Berenguer, J. / Rincon, D. / Miralles, P. / Nogales, O. / Yepes, I. / Nuñ / ez, O. / Clemente, G. et al. | 2006
- S69
-
165 Evaluation of four prognostic scores in patients with acute-on-chronic liver failureStauber, R. E. / Stadlbauer, V. / Struber, G. / Kaufmann, P. et al. | 2006
- S70
-
168 Prophylactic intravenous antibiotics do not influence the outcome of acute liver failureHassoun, Z. / Fournier, C. / Tessier, G. / Villeneuve, E. / Villeneuve, J. P. et al. | 2006
- S71
-
HBV virological assessmentHatzakis, A. / Magiorkinis, E. / Haida, C. et al. | 2006
- S73
-
175 Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to β-adrenergic stimulation in cirrhotic ratsEbrahimi, F. / Tavakoh, S. / Hajrasouliha, A. R. / Dehpour, A. R. et al. | 2006
- S74
-
178 Increased neo-angiogenesis and vascular endothelial growth factor (VEGF) protein expression in the lung of cirrhotic miceGeerts, A. M. / Bergiers, S. / Vanheule, E. / Van Vlierberghe, H. / De Vos, M. / Colle, I. et al. | 2006
- S75
-
180 Diffusion tensor and magnetisation transfer imaging of the brain at 3T in patients with cirrhosis and hepatic encephalopathyGrover, V. P. / Counsell, S. J. / Forton, D. M. / Bradford, E. J. / Saxby, B. K. / Thomas, H. C. / Hajnal, J. V. / Taylor-Robinson, S. D. et al. | 2006
- S76
-
183 Losartan in combination therapy of experimental rat liver fibrosis reversalLukivskayales, O. / Patsenker, E. / Popov, Y. / Schuppan, D. / Buko, V. et al. | 2006
- S77
-
186 The involvement of CB1 and VR1 receptors in cardiovascular disturbances of bile-duct ligated ratsMoezi, L. / Gaskari, S. A. / Liu, H. / Li, Y. / Dehpour, A. R. / Lee, S. S. et al. | 2006
- S77
-
Treatment options in HBVCraxi, A. / Antonucci, G. / Camma, C. et al. | 2006
- S78
-
189 Hepatic inflammation increases portal pressure through inhibition of eNOS activity — Potential mechanismsMookerjee, R. P. / Davies, N. A. / Hodges, S. J. / Dalton, R. N. / Turner, C. / Wiesenthal, A. / Schilling, K. / lcking, A. / Sen, S. / Williams, R. et al. | 2006
- S79
-
191 Opposite post translational regulation of endothelial no synthase (ENOS) by heat shock protein 90 and caveolin in liver and lungs from rats with hepatopulmonary syndromePastor, C. M. / Quadri, R. / Hadengue, A. / Cikirikcioglu, B. / Schiffer, E. / Bourquin, J. / Morel, D. / Frossard, J. L. et al. | 2006
- S80
-
194 Cirrhosis reversal by antifibrotic combination therapy: Potentiation of the antifibrotic effect of mycophenolate mofetil by pioglitazone and halofuginonePopov, Y. / Khokhar, A. / Patsenker, E. / Niedobitek, E. / Schuppan, D. et al. | 2006
- S81
-
197 Hepcidin and hemojuvelin gene expression in rat liver damage: In vivo and in vitro studiesSheikh, N. / Tron, K. / Dudas, J. / Saile, B. / Batusic, D. / Ramadori, G. et al. | 2006
- S82
-
200 Derangement of the hepatic microcirculation during the development of liver cirrhosis in the bile duct ligated (BDL) ratFrancis, R. J. / Wheatley, A. M. et al. | 2006
- S83
-
203 Noradrenaline vs terlipressin in hepatorenal syndrome: A prospective, randomized studyAlessandria, C. / Marzano, A. / Ottobrelli, A. / Debemardi-Venon, W. / Todros, L. / Torrani, M. / Morgando, A. / Balzola, E. / Martini, S. / Cacace, G. et al. | 2006
- S84
-
206 Safe use of peg-ifn and ribavirin in hcv-cirrhotic patients undergoing partial splenic embolizationBá / rcena, R. / Moreno, A. / Foruny, J. R. / Quereda, C. / Blazquez, J. / Gil-Grande, L. A. / Moreno, J. / Perez-Elias, M. J. / Antela, A. et al. | 2006
- S84
-
Candidates for therapy: HBVDusheiko, G. et al. | 2006
- S85
-
209 Angiotensin ii type 1 receptors blockade decreases pulmonary vascular resistance in cirrhotic patientsCastano, G. O. / Viudez, P. / Izus, M. / Mesquida, M. / Sookoian, S. et al. | 2006
- S89
-
221 Independent parameters associated with protein-energy malnutrition in cirrhosis: Prospective analysis of 105 patientsHrycewycz, N. / Bureau, C. / Peron, J. M. / Rouquet, O. / Dupuis, E. / Vinel, J. P. et al. | 2006
- S90
-
Treatment algorithm for chronic hepatitis B in HIV-infected patientsBenhamou, Y. et al. | 2006
- S93
-
232 Critical flicker frequency: Diagnostic tool for minimal hepatic encephalopathySharma, P. / Sharma, B. C. / Sarin, S. K. / Puri, V. et al. | 2006
- S94
-
235 Non-invasive predictors of advanced fibrosis in genetic haemochromatosis — do practice guidelines change practice?Thomas, J. A. / Watson, A. / Zaitoun, A. / Neal, K. / Gamble, S. / Goddard, W. P. / Long, R. G. / Ryder, S. D. / Aithal, G. P. et al. | 2006
- S95
-
Assessment of treatment efficacy in HBV infection and diseaseZoulim, F. et al. | 2006
- S96
-
240 Des-gamma-carboxy prothrombin-IgM immune complex as novel biomarker for hepatocellular carcinomaBeneduce, L. / Pesce, G. / Gallotta, A. / Fassina, G. et al. | 2006
- S97
-
243 Antioxidant supplements for prevention of liver cancerBjelakovic, G. / Nikolova, D. / Simonetti, R. G. / Gluud, C. et al. | 2006
- S99
-
249 Risk factors and patterns of extrahepatic metastasis of hepatocellular carcinomaChung, W. J. / Lee, H. S. / Kim, S. Y. / Lee, Y. S. / Chung, K. W. / Jang, B. K. / Park, K. S. / Cho, K. B. / Hwang, J. S. / Ahn, S. H. et al. | 2006
- S100
-
Update on HAART in HIVYeni, P. et al. | 2006
- S101
-
254 Effectiveness of radiological techniques in diagnosis of hepatocellular carcinoma. Correlation with liver explantsGarzó / n, M. / Pascasio, J. M. / Sousa, J. M. / Vargas, B. / Castell, E. J. / Gavilá / n, E. / Gó / mez, M. A. et al. | 2006
- S104
-
Prevention of viral hepatitis in HIV co-infectionBrook, G. et al. | 2006
- S108
-
Multiple viral infectionsGaeta, G. B. / Precone, D. F. / Cozzi-Lepri, A. / Cicconi, P. / Monforte, A. D. et al. | 2006
- S108
-
276 Internally cooled versus perfused electrodes for radiofrequency ablation (rfa) in patients with small (≤3 CM) hepatocellular carcinoma (HCC)Seror, O. / Nkontchou, G. / Tin-Tin Htar, M. / Barrucand, C. / Dordera, M. / Ganne-Carrie, N. / Trinchet, J. C. / Sellier, N. / Beaugrand, M. et al. | 2006
- S109
-
279 Novel splicing variant of the vitamin k-dependent γ-glutamyl carboxylase (GGCX) causes des-gamma-carboxyl prothrombin production in human hepatocellular carcinoma cell linesUeda, N. / Shiraha, H. / Fujikawa, T. / Suzuki, M. / Takaoka, N. / Nakanishi, Y. / Takaki, A. / Shiratori, Y. et al. | 2006
- S110
-
282 Modulation of pro-apoptotic p53 transcriptional targeting by bile acids in primary rat hepatocytesAmaral, J. D. / Castro, R. E. / Sola, S. / Rodrigues, C. M. et al. | 2006
- S112
-
288 Undisturbed response to dna damage in telomerase-immortalized human fetal hepatocytesHaker, B. / Knuth, N. / Diedrich, S. / Wege, H. et al. | 2006
- S113
-
291 Proteasome inhibitor induced G2/M arrest through upholding of wee1 kinase in human hepatocellular carcinoma (HCC)Kogiso, T. / Nagahara, H. / Shiratori, K. et al. | 2006
- S114
-
Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their managementMauss, S. et al. | 2006
- S115
-
296 Crosstalk between polyamine oxidation and protective effect of IGF-I in fas-induced acute liver failure: Perspectives for therapeutic interventionPavlovic, D. / Kocic, G. / Stojanovic, I. / Cvetkovic, T. / Jevtovic, T. / Bjelakovic, G. et al. | 2006
- S117
-
303 Hypoxic conformance of metabolism in primary rat hepatocytes: A model of hepatic hibernationSubramanian, R. M. / Chandel, N. / Budinger, S. / Schumacker, P. et al. | 2006
- S119
-
Antiviral hepatitis and antiretroviral drug interactionsPerronne, C. et al. | 2006
- S119
-
308 Coordinated periportal down-regulation of Bsep and Ntcp in experimental cholestasis is associated with induction of periportal Oatp1a4 and Oatp1b2Donner, M. G. / Schumacher, S. / Warskulat, U. / H↑ / ssinger, D. et al. | 2006
- S120
-
311 Regulation of hepatobiliary transporters in response to hypoxiaFouassier, L. / Beaussier, M. / Schiffer, E. / Rey, C. / Lasnier, E. / Scoazec, J. Y. / Lienhart, A. / Barbu, V. / Housset, C. et al. | 2006
- S121
-
314 The activation of IGF1 system is a requisite for cholangiocyte survival during the progression of primary biliary cirrhosis (PBC)Alvaro, D. / Floreani, A. / Onori, P. / Franchitto, A. / Mancino, M. G. / Guido, M. / Carpino, G. / De Santis, A. / Angelico, M. / Attili, A. E. et al. | 2006
- S122
-
317 A distention-contraction reflex in bile canalicular motilityMessner, J. / Reiberger, T. / Marischler, C. / Gajdzik, L. / Graf, J. et al. | 2006
- S123
-
320 3.5-Diethoxycarbonyl-1.4-dihydrocollidine (DDC) feeding induces cholestasis, chronic inflammatory bile duct damage and biliary fibrosis in miceStö / ger, U. / Fickert, E. / Fuchsbichler, A. / Moustafa, T. / Gumhold, J. / Silbert, D. / Zatloukal, K. / Denk, H. / Trauner, M. et al. | 2006
- S124
-
322 A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated ratsAdrian, J. E. / Kamps, J. A. / Scherphof, G. L. / Meijer, D. K. / Poelstra, K. et al. | 2006
- S125
-
325 Endotoxin-induced hsc activation involves pdgfr and egfr recruitmentBrun, P. / Martines, D. / Scarpa, M. / Palú / G. / Castagliuolo, I. et al. | 2006
- S126
-
328 Reduced cholestatic liver injury in mice deleted for insulin-like growth factor 1 receptor in hepatocytesCadoret, A. / Rey, C. / Wendum, D. / Holzenberger, M. / Housset, C. et al. | 2006
- S126
-
Assessment of liver fibrosis in co-infected patientsKelleher, T. B. / Afdhal, N. et al. | 2006
- S127
-
331 Tamoxifen may inhibit hepatic fibrogenesis by suppressing the activation of hepatic stellate cellsKim, J. A. / Chung, Y. H. / Jang, M. K. / Lee, J. K. / Choi, M. H. / Kim, S. H. / Ryu, S. H. / Shin, J. W. / Kim, K. M. / Lim, Y. S. et al. | 2006
- S128
-
334 Ursodeoxycholic acid improves rat liver fibrosis better than spontaneous recoveryMas, M. R. / Tasci, I. / Vural, S. A. / Cornern, B. / Alcigir, G. / Serdar, M. / Mas, N. / Isik, A. T. / Ates, Y. / Uzunalimoglu, O. et al. | 2006
- S129
-
337 Celecoxib, a selective cyclooxygenase-2 inhibitor, shows anti-proliferative, pro-apoptotic and anti-fibrotic effects in human hepatic stellate cellsPaik, Y. H. / Lee, K. S. / Lee, H. J. / Kang, S. H. / Ahn, S. H. / Han, K. H. / Chon, C. Y. / Moon, Y. M. et al. | 2006
- S130
-
340 GPO10, a collagen mimetic effectively promotes activation of collagen-bound pro-matrix-metalloproteinase-2 in fibrotic liver tissueRuehl, M. / Freise, C. / Seja, M. / Erben, U. / Schuppan, D. / Famdale, R. / Zeitz, M. / Somasundaram, R. et al. | 2006
- S131
-
343 MMP-9 overexpression in murine liver: Embryonic lethality and influence on liver homeostasis in juvenile miceThieringer, F. R. / Czochra, E. / Meyer, E. / Schmitt, U. / Anthon, B. / Garcia-Lazaro, J. E. / Lohse, A. W. / Galle, E. R. / Kanzler, S. et al. | 2006
- S132
-
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and managementNunez, M. et al. | 2006
- S133
-
349 Hepatic progenitor cells express VIP receptor type 2Cassiman, D. / De Vos, R. / Sinelli, N. / Vander Borght, S. / Petersen, B. / Bockx, I. / Aertsen, P. / Libbrecht, L. / Nevens, E. / Roskams, T. et al. | 2006
- S134
-
352 Analysis of the homeobox transcription factor Prox-1 expression in rat liver development and in different models of liver damage and regenerationDudas, J. / Elmaouhoub, A. / Mansuroglu, T. / Batusic, D. / Papoutsi, M. / Tron, K. / Saile, B. / Wilting, J. / Ramadori, G. et al. | 2006
- S135
-
355 Telomerase gene rescue promotes hepatocarcinogenesis in the context of p53- and telomere-dysfunction by limiting chromosomal instabilityLechel, A. / Holstege, H. / Begus, Y. / Schienke, A. / Kamino, K. / Geffers, R. / Lehmann, U. / Buer, J. / Manns, M. P. / Kubicka, S. et al. | 2006
- S136
-
358 High expression of claudin-7 during liver regenerationLó / di, C. / Szabo, E. / Batmunkh, E. / Holczbauer, A. / Kiss, A. / Illyé / s, G. / Paku, S. / Schaff, Z. et al. | 2006
- S137
-
360 Platelets promote liver regeneration after extensive hepatectomyMurata, S. / Matsuo, R. / Ikeda, O. / Ohkohchi, N. et al. | 2006
- S140
-
Management of end stage liver disease (ESLD): What is the current role of orthotopic liver transplantation (OLT)?Miro, J. M. / Laguno, M. / Moreno, A. / Rimola, A. / the, H. C. et al. | 2006
- S143
-
377 Recombinant viral vectors expressing sodium-iodide symporter for hepatocelllular carcinoma radiotherapyHerve, J. / Sa Cunha, A. / Liu, B. / Longuet, M. / Valogne, Y. / Roux, J. / Boisgard, R. / Tavitian, B. / Clerc, J. / Brechot, C. et al. | 2006
- S145
-
382 Identification of peptides binding to hepatocellular carcinomaShimizu, A. / Maruta, F. / Akita, N. / Miwa, S. / Miyagawa, S. et al. | 2006
- S146
-
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patientsBruno, R. / Puoti, M. / Sacchi, P. / Filice, C. / Carosi, G. / Filice, G. et al. | 2006
- S148
-
391 CD8 T cell hyporesponsiveness in chronic HBV infection: Role of CD3-ZETA downregulationDas, A. / Kennedy, P. / Lopes, A. R. / Dunn, C. / Gilson, R. J. / Bertoletti, A. / Maini, M. K. et al. | 2006
- S149
-
395 Role of circulating IL-10 in acute viral hepatitisNebbia, G. / Northfield, J. / Barnest, E. / Emery, V. / Brown, D. / Willberg, C. / Dusheiko, G. / Klenerman, P. / Fabris, P. et al. | 2006
- S150
-
398 Differential transcriptional responses to interferons in primary liver cells and their modulation by anti-inflammatory cytokinesGrü / newald, P. / Trippler, M. / Wut, J. / Lu, M. / Gerken, G. / Schlaak, J. F. et al. | 2006
- S151
-
401 The functional domain and mechanism of hepatocyte nuclear factor 30 (HNF3β) in inhibition of HBV replicationTang, H. / Huang, E. J. / Hel, F. / Liu, L. / Wang, S. / Liu, E. J. / Zhou, T. Y. / Zhao, L. S. et al. | 2006
- S152
-
404 Detection of HCV-RNA in the liver of anti-HCV positive patients with persistently normal alt levels and serum HCV-RNA negativeCarreñ / o, V. / Pardo, M. / Ló / pez-Alcorocho, J. M. / Rodrí / guez-Iñ / igo, E. / Bartolomé / J. et al. | 2006
- S153
-
407 HCV NS5A protein — functional analysis using a BVDV replicon reporter system shows a correlation between in vitro effects on interferon sensitivity and clinical outcomeJones, M. / Strang, A. L. / Hibbert, L. / Smith, P. L. / Jacobs, M. G. / Foster, G. R. et al. | 2006
- S154
-
410 Modifying effect of hepatitis C virus (HCV) load in naive lymphoid cells on the detection of occult HCV infection following stimulation of the cells with mitogensPham, T. N. / Michalak, T. I. et al. | 2006
- S155
-
413 Bayesian coalescent inference of hepatitis C virus introduction from molecular sequences: The camporeale modelArgentini, C. / Genovese, D. / Ferraro, D. / Giordano, V. / Giglio, M. / Taffon, S. / Craxi, A. / Stroffolini, T. / Di Stefano, R. / Ranicetta, M. et al. | 2006
- S156
-
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infectionSagnelli, E. / Argentini, C. / Coppola, N. / Genovese, D. / Pisaturo, M. / Taffon, S. / Sagnelli, C. / Rapicetta, M. et al. | 2006
- S158
-
422 Virus-specific T-cell responses associated with HCV RNA persistence in the liver after apparent recovery from HCV infectionQuiroga, J. A. / Llorente, S. / Castillo, I. / Rodrí / guez-Iñ / igo, E. / Pardo, M. / Carreñ / o, V. et al. | 2006
- S159
-
425 Enhanced apoptosis of CD4+CD25+ T-regulatory lymphocytes in chronic HCV infection: Association with autoimmunityKovalev, Y. / Kessel, A. / Perr, R. / Naschitz, J. E. / Toubi, E. / Zuckerman, E. et al. | 2006
- S160
-
428 T cell chemokine receptor expression and chemotaxis, associated to TH1/TC1 response, in hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV)-HCV co-infectionCalvino, M. / Larrubia, J. R. / Sanz, E. / Pé / rez, J. / Benito, S. / Gonzá / lez, E. / Perna, C. / Montes, M. et al. | 2006
- S161
-
431 Co-inhibitory molecule B7-H1 may play an important role for chronicity of hepatitis CLee, Y. J. / Park, S. J. / Jee, S. R. / Lee, S. H. / Seol, S. Y. / Chung, J. M. / Jeong, H. Y. / Seo, S. K. / Park, S. G. / Cho, I. H. et al. | 2006
- S162
-
434 Detection of a new autoantibody in patients with chronic HCV infectionLiaskos, C. / Bogdanos, D. P. / Norman, G. / Rigopoulou, E. I. / Vergani, D. / Dalekos, G. N. et al. | 2006
- S163
-
437 Intrahepatic NKT and T-regulatory lymphocytes cytokine profile in end stage hepatitis C related chronic liver diseaseMorsy, M. A. / Norman, E. J. / Mitry, R. / Heaton, N. D. / Vaughan, R. W. et al. | 2006
- S164
-
440 Increased TGFβ1 secretion via down-regulating NKG2D killer activator receptor expression results in impaired natural killer cell activity in patients with chronic HCV hepatitisPar, G. / Berki, T. / Palinkas, L. / Szereday, L. / Halasz, M. / Szekeres-Bartho, J. / Miseta, A. / Hegedí / s, G. / Fausts, Z. et al. | 2006
- S165
-
443 Hepatitis C virus promotes angiopoietin-2 expression in liver tissue of patients with chronic hepatitis CSanz-Cameno, P. / Martí / n-Ví / lchez, S. / Borque, M. J. / Moreno-Monteagudo, J. A. / Garcí / a-Buey, L. / Ló / pez-Cabrera, M. et al. | 2006
- S166
-
446 Contribution of auto-immune reactions involving cytochrome P4502E1 to hepatocyte injury during chronic hepatitis CVidali, M. / Occhino, G. / Ivaldi, A. / Serino, R. / Moia, S. / Rigamonti, C. / Sartorie, M. / Albano, E. et al. | 2006
- S167
-
449 Hepatitis C virus structural proteins and activation of Toll-like receptors 2 and 4Hoffmann, M. / Zeisel, M. B. / Barth, H. / Gissler, B. / Jilg, N. / Paranhos-Baccalà / r, G. / Wakita, T. / Golenbock, D. T. / Blum, H. E. et al. | 2006
- S168
-
451 High prevalence of hepatitis B virus infection in B-cell non-hodgkin lymphomaBorentain, P. / Colson, P. / Motte, A. / Moa, V. / Henry, M. / Botta, D. / Tamalet, C. / Gerolami, R. et al. | 2006
- S169
-
455 Prospective comparison of fibroscan and fibrotest in inactive hepatitis B carriersCastera, L. / Foucher, J. / Bernarde, P. H. / Saudo, A. / Bertet, J. / Couzigou, P. / de Ledinghen, V. et al. | 2006
- S170
-
458 HBsAg level in serum and liver in genotype B and C infected chinese chronic hepatitis B patients and their changes under peginterferon-alpha-2a treatmentChen, J. J. / Hou, J. L. / Ma, S. W. / Wang, Z. H. / Zhu, Y. E. / Luo,, K. X. / Naoumov, N. V. et al. | 2006
- S171
-
460 Hepatitis E in rural EnglandDalton, H. R. / Thurairajah, P. / Fellows, H. J. / Hussaini, S. H. / Mitchell, J. / Bendall, R. / Banks, M. / Ijaz, S. / Teo, C. G. / Levine, D. E. et al. | 2006
- S172
-
463 Clinical and virological characteristics of HBeAg-negative patients with chronic hepatitis B in china from 2000 to 2003Hou, J. L. / Yang, C. G. / Yu, L. C. / Chen, J. J. / Sun, J. / Luo, K. X. / Zhu, Y. E. / Guo, Y. B. et al. | 2006
- S173
-
466 Common osteopontin haplotype associated with chronic HBV infection and HCC occurrenceKim, Y. J. / Yoon, J. H. / Lee, H. S. / Park, B. L. / Shin, H. D. et al. | 2006
- S174
-
469 Inactive HBsAg carriers in central Italy. Cross-sectional and initial prospective data of the hep B free observational studyPiccolo, P. / Telesca, C. / Lenci, I. / Di Paolo, D. / Bandiera, E. / De Melia, L. / Sorbello, O. / De Santis, A. / Antonucci, G. / Longo, M. A. et al. | 2006
- S176
-
474 Hepatitis B virus genomic markers for hepatocellular carcinoma on full-genome sequencing of 332 patientsSung, J. J. / Tsui, S. K. / Tse, C. H. / Ng, E. Y. / Leung, K. S. / Lee, K. H. / Mok, T. S. / Bartholomeusz, A. / Au, T. C. / Zhang, M. D. et al. | 2006
- S177
-
477 High rates of hepatitis B virus reverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantationViganò / M. / Venere, C. / Soligo, D. / Lanfranchi, E. / Lambertenghi Deliliers, G. / Colombo, M. / Lampertico, P. et al. | 2006
- S178
-
480 Treatment with adefovir alone or in combination with lamivudine in chronic hepatitis B lamivudine-resistant patients: Results after two yearsBarbon, V. / Marzano, A. / Carenzi, S. / Lagget, M. / Alessandria, C. / Olivero, A. / Gaia, S. / Ciancio, A. / Smedile, A. / Rizzetto, M. et al. | 2006
- S179
-
483 Final analysis of virological outcomes and resistance during 5 years of adefovir dipivoxil monotherapy in HBeAg-negative patientsBorroto-Esoda, K. / Arterburn, S. / Snow, A. / Chuck, S. / Hadziyannis, S. / Locamini, S. / Zoulim, E. / Pawlotsky, J. M. et al. | 2006
- S181
-
488 Virodynamic predictors of treatment response to peginterferon and lamivudine combination treatment of HBeA-positive chronic hepatitis BChan, H. L. / Mihm, U. / Zeuzem, S. / Chim, A. M. / Hui, A. Y. / Wong, V. W. / Sung, J. J. / Herrmann, E. et al. | 2006
- S182
-
491 Peginterferon alpha-2a (40KD) (PEGASYS) reverses cirrhosis, improves fibrosis and slows progression of fibrosis in patients with HBeAg-positive or HBeAg-negative chronic hepatitis B (CHB)Cooksley, G. / Lau, G. K. / Marcellin, P. / Piratvisuth, T. / Bonino, E. / Luo, K. X. / Hadziyannis, S. / Jin, R. / Button, P. / Pluck, N. et al. | 2006
- S183
-
493 Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 yearGane, E. / Lai, C. L. / Liaw, Y. E. / Thongsawat, S. / Wang, Y. / Cheng, Y. / Heathcote, J. / Rasenacks, J. / Bzowej, N. / Naoumov, N. et al. | 2006
- S184
-
495 Tenofovir (TNV) has stronger antiviral effect than adefovir dipivoxil (ADV) against lamivudine (LAM) resistant hepatitis B virus (HBV)Hann, H. W. / Chae, H. B. / Dunn, S. R. et al. | 2006
- S185
-
498 Efficacy and safety of entecavir in Japanese adult patients with incomplete response to current lamivudine treatment: A phase II clinical trialKarino, Y. / Toyota, J. / Kumada, H. / Katano, Y. / Izumi, N. / Shiratori, Y. / Sata, M. / Seriu, T. / Omata, M. et al. | 2006
- S186
-
501 Lamivudine therapy in children with chronic hepatitis BLiberek, A. / Szaflarska-Poplawska, A. / Korzon, M. / Luczak, G. / Gora-Gebka, M. / Los Rycharska, E. / Balko, W. / Sikorska-Wisniewska, G. / Szlagatys-Sidorkiewicz, A. / Czerwionka-Szaflarska, M. et al. | 2006
- S190
-
512 Entecavir (ETV) demonstrates consistent responses throughout baseline disease and demographic subgroups for the treatment of lamivudine-refractory HBeAg(+) patients with chronic hepatitis BYurdaydin, C. / Senturk, H. / Boron-Kaczmarska, A. / Raptopoulou-Gigi, M. / Batur, Y. / Goodmans, Z. / Vaughah, J. / Brett-Smith, H. / Hindes, R. et al. | 2006
- S191
-
515 Non-response and resistance to adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistanceValdes, A. / Buti, M. / Jardi, R. / Rodriguez-Frias, E. / Schaner, M. / Esteban, R. / Guardia, J. et al. | 2006
- S194
-
522 Absence of pharmacokinetic drug-drug interaction between telbivudine and peginterferon alpha-2a or cyclosporine in healthy subjectsZhou, X. J. / Fielman, B. / Dubuc-Patrick, G. / Chao, G. / Brown, N. et al. | 2006
- S195
-
525 Hepatitis virus C RNA quantification by automated cobas ampliprep-cobas taqman 48 (CAP-CTM) real-time PCR assay. An evaluation of performanceChevaliez, S. / Bouvier-Alias, M. / Dameron, G. / Darthuy, E. / Remire, J. / Pawlotsky, J. M. et al. | 2006
- S196
-
528 Performance evaluation of 3 commercially available qunatitative HCV tests in the clinical settingRoudiere, L. / Ottomani, L. / Mondain, A. M. / Perney, P. / Blanc, F. / Larrey, D. / Ducos, J. et al. | 2006
- S199
-
536 Changes in NF-KB activation and iNOS and Mn-SOD gene expression during the progression to hepatocarcinoma in patients with chronic HCV infectionCuevas, M. J. / Almar, M. / Montoya, P. / Lima, E. / Olcoz, J. L. / Gonzalez-Gallego, J. / Jorquera, F. et al. | 2006
- S202
-
544 Accuracy of two new predictive models in assessing fibrosis in chronic hepatitis C (CHC)Paggi, S. / Fraquelli, M. / Conte, D. / Colombo, M. / Viganò / M. / Facciotto, C. / Dal Poggio, P. / Colli, A. et al. | 2006
- S203
-
547 Epidemiology and natural course of hepatitis C in Greece: Results of the nationwide HEPNET Greece cohort studyRantonoulou, M. / Tzoumakliotis, D. / Nikolopoulou, G. / Skoutelis, A. / Dalekos, G. / Dimopoulou, M. / Angelidou, K. / Avgerinos, A. / Chatiis, G. / Manolakopoulos, S. et al. | 2006
- S205
-
552 Angiotensin converting enzyme gene I/D polymorphism and liver fibrosis in chronic hepatitis CSmirne, C. / Fabris, C. / Toniutto, P. / Caldera, F. / Mella, R. / Bitetto, D. / Fumagalli, S. / Rossi, E. / Minisini, R. / Ceriani, E. et al. | 2006
- S206
-
555 Spontaneous resolution of chronic genotype 2 and 3 hepatitis C virus infection after apparently ineffective pegylated interferon and ribavirin therapy. A four-year prospective controlled studyAnnicchiarico, B. E. / Siciliano, M. / Avolio, A. W. / Bombardieri, G. et al. | 2006
- S207
-
558 Risk factors for bacterial infections in HIV/HCV-coinfected patients during interferon plus ribavirin-based therapyBani-Sadr, F. / Carrat, F. / Goderel, I. / Driiss, H. / Pol, S. / Cacoub, P. / Perronne, C. et al. | 2006
- S208
-
561 Safety and pharmacokinetics of the now nucleoside polymerase inhibitor, HCV-796: Results of a randomized, double-blind, placebo-controlled, ascending single-dose study in healthy subjectsChandra, P. / Raible, D. / Moyer, L. / Harper, D. / Speth, J. / Villano, S. / Fruncillo, R. et al. | 2006
- S210
-
566 Pharmacokinetics and pharmacodynamics of induction doses of peginterferon alpha-2a (40KD) (PEGASYS®) and ribavirin (COPEGUS®) in HCV genotype 1 patients who failed to respond to interferon/ribavirinDiago, M. / Romero-Gomez, M. / Crespo, J. / Olveira, A. / Perez, R. / Barcena, R. / Sanchez-Tapias, J. M. / Munoz-Sanchez, M. et al. | 2006
- S212
-
572 Predictive value and predictive factors of the rapid virological response in chronic hepatitis C treatmentGaleras, J. A. / Gimé / nez, M. D. / Má / rouez, C. / Cirera, I. / Coll, S. / Solà / R. et al. | 2006
- S213
-
575 Retreatment with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in pegylated interferon α-2b (12KD)/ribavirin non-responders with cirrhosis/advanced fibrosis: Repeat interim analysisGitlin, N. / Jensen, D. / Di Bisceglie, A. / Berg, T. / Salmeron, J. / Rizzetto, M. / Yurdaydin, C. / Marcellin, P. et al. | 2006
- S214
-
578 Uptake of hepatitis C virus (HCV) treatment among injection drug users (IDUS) in Vancouver, CanadaGrebely, J. / Conway, B. / Raffa, J. / Lai, C. / Krajden, M. / Tyndall, M. W. et al. | 2006
- S215
-
581 Hepatitis C virus treatment in injecting drug users: Frequency of contraindications and prognostic markers in participants of the Swiss hepatitis C cohort studyDober, S. / Isler, M. / Meili, D. / Bruggmann, P. et al. | 2006
- S216
-
583 Safety of peginterferon α-2a (40KD) (PEGASYS®) [PEG-IFNα-2a (40KD)] plus ribavirin (COPEGUS®) among pegylated interferon α-2b (12KD)/ribavirin non-responders: Interim analysis of the repeat studyJensen, D. / Andreone, F. / Benhamou, Y. / Horsmans, Y. / Diago, M. / Olveira Martins, A. / Teuber, G. / Rincon, D. / Marcellin, F. et al. | 2006
- S219
-
591 A prospective, multicenter, observational study on compliance to hepatitis C treatments (CHEOBS): Characteristics of HCV-infected patients with psychiatric disordersLang, J. P. / Meline, P. / Ouzan, D. / Cattan, L. / Chousterman, M. / Michels, R. / Fontanges, T. / Marcellin, P. / Cacoub, P. et al. | 2006
- S220
-
594 Natural course of treated and untreated chronic HCV infection: Results of the nationwide HEPNET. Greece cohort studyManesis, E. K. / Papatheodoridis, G. V. / Touloum, G. / Karafoulidou, A. / Ketikoglou, J. / Kitis, G. E. / Antoniou, A. / Kanatakis, S. / Koutsounas, S. J. / Vafiadis, I. et al. | 2006
- S221
-
597 Genotype and fibrosis stage are major predictors of sustained virological response to retreatment with pegylated combination in non responders to standard combination therapyMoukari, R. / Ripault, M. P. / Asselah, T. / Boyer, N. / Martinot, M. / El Ray, A. / Vidaud, D. / Cazals-Hatem, D. / Valla, D. / Marcellin, P. et al. | 2006
- S222
-
600 Association of metabolic syndrome, diabetes, iron metabolism and steatosis in HCV and HBV related chronic hepatitis: Differences and similaritiesMasarone, M. / La Mura, V. / Moschella, E. / Svelto, M. / Carrino, E. / Torella, R. / Persico, M. et al. | 2006
- S223
-
603 Insulin resistance in co-infected HCV/HIV patients: A negative factor influencing sustained response to peginterferon plus ribavirinRomero-Gomez, M. / Tural, C. / Sola, R. / Martinez-Sierra, M. C. / Viloria, M. M. / Jimenez, M. D. / Arizcorreta, A. / Trabadela, C. / Clotet, B. / Planas, R. et al. | 2006
- S224
-
Alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment naive japanese chronic hepatitis C patients: A randomised, double-blind, multicentre, phase iii trialSakai, T. / Iino, S. / Okuno, T. / Omata, M. / Kiyosawa, K. / Kumada, H. / Yamada, G. / Hayashi, N. et al. | 2006
- S226
-
610 Antifibrotic effects of losartan administration in patients with chronic hepatitis CSookoian, S. / Ferná / ndez, M. A. / Castañ / o, G. O. et al. | 2006
- S227
-
613 Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirinTrapero-Marugan, M. / Garcia-Buey, L. / Muñ / oz, C. / Moreno-Monteagudo, J. A. / Borque, M. J. / Salcedo-Mora, X. / Moreno-Otero, R. et al. | 2006
- S230
-
620 Presence of CD4-positive cells in the portal tract on pretreatment liver biopsy is associated with early viral reduction during antiviral treatment of HCVWestin, J. / Lagging, M. / Romero, A. / Norkrans, G. / Pawlotsky, J. M. / Neumann, A. / Ferrari, C. / Schalm, S. / Zeuzem, S. / Negro, E. et al. | 2006
- S231
-
623 Safety and pharmacokinetics of NM107 following intravenous infusion of escalating doses in healthy volunteers: Determination of absolute oral bioavailability of valopicitabine (NM283)Zhou, X. J. / Knox, S. / Fielman, B. / Chao, G. / Brown, N. et al. | 2006
- S232
-
626 In vitro immunosuppressive effect of vitamin D3 in primary biliary cirrhosisAlmerighi, C. / Bogdanos, D. P. / Cholongitas, V. / Carey, I. / Meda, E. / Hussain, M. J. / Burroughs, A. K. / Vergani, D. et al. | 2006
- S233
-
629 Identification of new autoantigens on liver plasma membranes in type 1 autoimmune hepatitis by proteome analysisBallot, E. / Le Naour, F. / Tahiri, E. / Huguet, S. / Gigou, M. / Johanet, C. / Samuel, D. / Duclos Vallee, J. C. et al. | 2006
- S234
-
632 Four-year outcome of primary sclerosing cholangitis (PSC) under low-dose ursodeoxycholic acid (UDCA): A French prospective studyGarioud, A. / Seksik, P. / Chretien, Y. / Corpechot, C. / Poupon, R. / Poupon, R. E. / Chazouillè / res, O. et al. | 2006
- S235
-
635 High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effectiveCullen, S. N. / Rust, C. / Fleming, K. / Beuers, U. / Chapman, R. W. et al. | 2006
- S237
-
640 Alleviation of ConA immune mediated hepatitis via glycolipids: The role of beta versus alpha configuration in determining NKT lymphocyte distribution and the TH1/TH2 paradigmLalazar, G. / Preston, S. / Lador, A. / Panno, O. / Zolotarov, L. / Ilan, Y. et al. | 2006
- S238
-
643 Defective CD4+CD25+ T-regulatory cell ability to induce TGF-β secretion in autoimmune hepatitis is associated with reduced level of TGF-β gene expressionLonghi, M. S. / Mitry, R. R. / Mieli-Vergani, G. / Vergani, D. / Ma, Y. et al. | 2006
- S239
-
646 Once-weekly compared with daily alendronate for low bone mass in women with primary biliary cirrhosisPares, A. / Vazquez, I. / Alvarez, L. / Caballeria, L. / Pons, E. / Cerda, D. / Peris, E. / Monegal, A. / Guañ / abens, N. et al. | 2006
- S240
-
649 high frequency of X chromosome abnormalities in short stature women with unexplained elevated liver enzymesRoulot, D. / Malan, V. / Bourcier, V. / Benzacken, B. / Ziol, M. / Beaugrand, M. et al. | 2006
- S241
-
652 Juvenile autoimmune sclerosing cholangitis is associated with possession of HLA DRB1*13Underhill, J. / Liaskos, C. / Bogdanos, D. E. / Cheeseman, E. / Mieli-Vergani, G. / Vergani, D. / Mae, Y. et al. | 2006
- S244
-
662 Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patientsRiva, A. / Pelucchi, S. / Bovo, G. / Trombini, P. / Salvioni, A. / Mariani, R. / Vergani, A. / Casati, G. / Fargion, S. / Piperno, A. et al. | 2006
- S247
-
670 Morbidly obese patients with or whitout nash and type 2 diabetes have increased inflammatory C-reactive protein in both liver and adipose tissueAnty, R. / Bekri, S. / Luciani, N. / Saint Paul, M. C. / Dahman, M. / Iannelli, A. / Ben Amor, I. / Staccini-Myx, A. / Huet, P. M. / Gugenheim, J. et al. | 2006
- S249
-
676 The fatty liver index: A simple and accurate predictor of hepatic steatosisCastiglione, A. / Bedogni, G. / Miglioli, L. / Crocè / L. S. / Masutti, E. / Passalacqua, M. / Bellentani, S. et al. | 2006
- S250
-
679 Prevalence and factors associated with nash and liver fibrosis in morbidly obese subjectsCressend, T. / Trouette, H. / Collet, D. / Sa Cunha, A. / Vergniol, J. / Blond, P. / Adhoute, X. / Masson, B. / de Ledinghen, V. et al. | 2006
- S251
-
682 Relationship between dietary intake and liver histology in non-alcoholic fatty liver diseaseFederico, A. / Trappoliere, M. / Coppola, E. / D'Auria, M. / Del Vecchio Blanco, C. / Loguercio, C. et al. | 2006
- S252
-
685 A role for p66shc and mitochondrial ROS in ethanol hepatotoxicity and alcoholic fatty liverKoch, O. R. / Fusco, S. / Palozza, P. / Larocca, L. M. / Cravero, A. / Farré / S. / Pani, G. / Galeotti, T. et al. | 2006
- S253
-
688 Non-invasive tests of liver fibrosis in NAFLD: A systematic reviewGuha, I. N. / Parkes, I. / Roderick, P. R. / Rosenberg, W. M. et al. | 2006
- S254
-
690 Statins in patients with elevated liver enzymes because of non-alcoholic fatty liver disease (NAFLD): A clinical and histopathological follow-up studyEkstedt, M. / Franzé / n, L. E. / Mathiesen, U. L. / Bodemar, G. / Kechagias, S. et al. | 2006
- S255
-
693 Manganese superoxide dismutase overexpression protects against hepatic mitochondrial dna depletion after an acute alcohol binge, yet aggravates mitochondrial DNA depletion after chronic alcohol intoxication in miceLarosche, I. / Letté / ron, P. / Fromenty, B. / Abbey-Toby, A. / Vadrot, N. / Feldmann, G. / Van Remmen, H. / Richardson, A. / Pessayre, D. et al. | 2006
- S256
-
696 Simultaneous presence of tumor necrosis factor receptor 2 and tumor necrosis factor promoter gene polymorphisms associates with alcoholic liver diseaseMachado, M. V. / Martins, A. / Cortez-Pinto, H. / Almeida, R. / Marques-Vidal, P. / Gonç / alves, M. S. / Carneiro de Moura, M. / Camilo, M. E. et al. | 2006
- S257
-
699 Nateglinide improves non-alcoholic steatohepatitis (NASH) with type 2 diabetesMorita, Y. / Ueno, T. / Sasaki, N. / Tateishi, Y. / Nagata, E. / Kage, M. / Sata, M. et al. | 2006
- S258
-
702 Liver peroxisomes release H2O2 into the cytoplasm via microtubules: Direct evidence for peroxisomes as essential oxidative stress sourceFritz, R. / Bol, J. / Aneermuller, S. / Fahimi, H. D. / Volkl, A. / Mueller, S. et al. | 2006
- S259
-
705 Screening of severe liver fibrosis in the general population and by GPOberti, E. / Cailliez, E. / Fouchard-Hubert, I. / Robin, B. / Gallois, Y. / Rabouin, F. / Ternisien, C. / Dubois, E. / Lebot, B. / Soulard, G. et al. | 2006
- S260
-
7088 A lipidomic analysis of non-alcoholic fatty liver disease (NAFLD)Puri, P. / Baillie, R. A. / Wiest, M. / Mirshahi, F. / Sanyal, A. J. et al. | 2006
- S261
-
711 Pentoxifylline protects genetically obese mice from ethanol-induced hepatic apoptosisRobin, M. A. / Demeilliers, C. / Sutton, A. / Paradise, V. / Maisonneuve, C. / Dubois, S. / Poirel, O. / Letté / ron, P. / Pessayre, D. et al. | 2006
- S262
-
714 Hypoadiponectinemia is associated with insulin resistance in patients with non-hfe related hepatic iron overloadSalvioni, A. / Corbetta, S. / Trombini, P. / Vergani, A. / Coletti, S. / Beck-Peccoz, P. / Spadal, A. / Piperno, A. et al. | 2006
- S263
-
737 Circulating and adipose tissue expression of visfatin in non-alcoholic fatty liver diseaseSoardol, G. / Pagano, C. / Donnini, D. / Pilone, C. / Domenis, L. / Azzolini, R. / Olivieri, M. / Milocco, C. / Vettor, R. / Sechi, L. et al. | 2006
- S265
-
722 Identification and characterization of homo sapiens submergence induced protein 2 (ESIP-L) in NAFLD: A diagnostic and molecular approachTsimako, M. E. / Kroon, P. / Wilce, P. et al. | 2006
- S266
-
725 Liver involvement in acute vaso-occlusive crisis of patients with sickle cell disease: Prevalence and predisposing factorsSevastos, N. / Koskinas, J. / Zacharakis, G. H. / Galiatsos, N. / Manesis, E. / Archimandritis, A. J. et al. | 2006
- S271
-
736 Early clearance of HCV RNA with valopicitabine (NM283) plus PEG-Interferon in treatment-naïve patients with HCV-1 infection: First results from a phase IIb trialDieterich, D. / Lawitz, E. / Nguyen, T. / Younes, Z. / Santoro, J. / Gitlin, N. / McEniry, D. / Chasen, R. / Goff, J. / Knox, S. et al. | 2006
- S273
-
740 Emergence of dual-resistance HBV mutations to adefovir-dipivoxil and lamivudine in a hepatitis B patient with combination therapy for adefovir resistanceKwon, S. Y. / Lee, C. H. / Choi, W. H. / Yeon, J. E. / Byun, K. S. et al. | 2006
- S276
-
747 Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis BNaoumov, N. / Lai, C. L. / Gane, E. / Liaw, Y. E. / Thongsawat, S. / Wang, Y. / Heathcote, E. J. / Rasenack, J. / Bzowej, N. / Chao, G. et al. | 2006
- S277
-
749 A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase IIA clinical trialSchneider, J. / Halota, W. / Delic, D. / Nesic, Z. / Prokopowicz, D. / Flisiak, R. / Kuydowicz, J. / Jankowski, M. / Cianciara, J. / Mach, T. et al. | 2006
- S279
-
Author index| 2006
- XXI
-
Subject Index| 2006
-
Acknowledgements| 2006
-
17 Chemokine dependent recruitment of dendritic cell precursors across human liver sinusoidal endotheliumAspinall, A. I. / Curbishley, S. M. / Lalor, P. F. / Adams, D. H. et al. | 2006
-
24 A new developed self-expanding metal stent as a treatment of acute esophageal variceal bleedingHubmann, R. / Bodlaj, G. / Czompo, M. / Benkö / L. / Pichler, P. / Al-Kathib, A. / Kiblbö / ck, P. / Shamiyeh, A. et al. | 2006
-
33 Regulatory T cells contributed partially to the defective functions of virus-specific exhausted CD8+T cells in patients with chronic hepatitis B virus infectionLin, C. Y. / Tsai, M. C. / Huang, C. T. / Hsu, C. W. / Chien, R. N. / Chen, Y. C. / Sheen, I. S. / Liaw, Y. F. et al. | 2006
-
36 Pharmacokinetics and pharmacodynamics of pradefovir, a liver-targeting prodrug of PMEA in HBV patientsLin, C. / Xu, C. / Yeh, L. / Sullivan-Bolyai, J. / Xu, Y. et al. | 2006
-
40 Protective memory CD8 responses are generated in self-limited but not in persistent HCV infectionUrbani, S. / Amadei, B. / Tola, D. / Fisicaro, P. / Cerioni, S. / Missale, G. / Ferrari, C. et al. | 2006
-
61 Differential characteristics of primary occult (POI) and secondary occult (SOI) hepadnaviral infectionsMichalak, T. I. / Mulrooney-Cousins, P. M. / Coffin, C. S. / Pham, T. N. / Gujar, S. A. et al. | 2006
-
62 Common bile-duct-ligation of FXR knockout mice results in severe hepatic steatosis due to enhancement in lipogenic gene expressionMoustafa, T. / Fickert, P. / Prokesch, A. / Wagner, M. / Fuchsbichler, A. / Silbert, D. / Gumhold, J. / Denk, H. / Trajanoski, Z. / Trauner, M. et al. | 2006
-
74 In vivo endothelial engraftment of multipotent adult progenitor cells in a rat hepatocarcinoma modelFranchi, F. / Barajas, M. A. / Aranguren, X. / Clavel, C. / Abizanda, G. / Moreno, C. / Yang, G. / Fernandez, V. / Qian, C. / Prosper, F. et al. | 2006
-
123 Pegylated interferon alpha-2a treatment in HCV positive patients after liver transplantationNeumann, U. P. / Bahra, M. / Berg, T. / Scmeding, M. / Langrehr, J. M. / Neuhaus, P. et al. | 2006
-
157 Importance of splanchnic Doppler parameters for the evaluation of liver damage progression after HCV reinfection in liver transplant patientsBolognesi, M. / Quaglo, C. / Bombonato, G. / Guido, M. / Merkel, C. / Rugge, M. / Gatta, A. / Sacerdoti, D. et al. | 2006
-
166 Glucose metabolism in living-donor liver transplantation correlates with liver function and IGF-1Stockmann, M. / Nolting, S. / Konrade, T. / Hiinerbein, D. / Dö / bling, H. / Neuhaus, P. et al. | 2006
-
196 The mechanisms of sodium and free-water retention in experimental preascitic liver cirrhosis: A physiopathological studySansoe, G. / Aragno, M. / Rosina, F. / Smedile, A. / Rizzetto, M. et al. | 2006
-
218 JAK2 V617F mutation in extrahepatic portal vein obstruction and budd-chiari syndromeFabris, E. M. / Reati, R. / Dell'Era, A. / Bucciarelli, P. / Bergamaschi, G. / Barosi, G. / Primignani, M. et al. | 2006
-
230 Usefulness of the measurement of critical flicker frequency in the diagnosis of minimal hepatic encephalopathy (MHE)Romero-Gomez, M. / Cordoba, J. / Jover, R. / Del-Olmo, J. A. / Ramí / rez, M. / Flavia, M. / Compañ / y, L. / Nuñ et al. | 2006
-
278 mTOR Inhibition for patients with hepatocellular carcinoma undergoing liver transplantation: Is there a rationale?Sieghart, W. / Fuereder, T. / Schmid, K. / Cejka, D. / Wrba, E. / Wang, X. / Gruber, D. / Rasoul-Rockenschaub, S. / Peck-Radosavljevic, M. / Wacheck, V. et al. | 2006
-
285 The impact of hcv core protein-related cell cycle modulation on hepatic regeneration and inflammation - an in vivo study based on conditional HCV core transgenicsChang, M. L. / Yeh, C. T. / Sheen, I. S. / Tai, D. I. / Lin, S. M. / Chen, J. C. / Chiu, C. T. / Lin, D. Y. et al. | 2006
-
301 P38MAPK and PKR dependent cyclin B1 delocalization in HCV core expressing cellsSpaziani, A. / Alisi, A. / Sanna, D. / Balsano, C. et al. | 2006
-
347 Overexpression of the Wnt/frizzled signal's members: A common and early event in human hepatocellular carcinoma (HCC)Bengochea, A. / De Souza, M. / Lefrancois, L. / Trepo, C. / Kim, M. / Wands, J. R. / Hainaut, P. / Scoazec, J. Y. / Vitvitski, L. / Merle, P. et al. | 2006
-
427 Characterisation of HCV core-specific adaptive regulatory T cell clones from patients with chronic hepatitis C infectionLanghans, B. / Braunschweiger, I. / Nieschalke, H. D. / Sauerbruch, T. / Spengler, U. et al. | 2006
-
435 Serum concentration of hepatocyte growth factor is related to histological fibrosis stage in patients with hepatitis C virus chronic liver diseaseMarí / n-Serrano, E. / Giró / n-Gonzá / lez, J. A. / Tejada-Cabrera, M. / Rodrí / guez-Ramos, C. / Dí / az-Garcí et al. | 2006
-
448 Decline of HCV-specific CD8+ T cells during interferon-alpha therapy of acute hepatitis C (HCV): Role of apoptosis vs. differential regulation of chemokine receptorsWiegand, J. / Wedemeyer, H. / Ciner, A. / Schlaphoff, V. / Buggisch, P. / Jaeckel, E. / Manns, M. P. / Comberg, M. et al. | 2006
-
450 Hepatitis C virus core protein inhibits priming of CD8 and CD4 T cell responses by myeloid dentritic cells in vitroZimmermann, M. / Flechsig, C. / Haugg, K. / Adler, G. / Dikopoulos, N. et al. | 2006
-
471 HBsAg polymorphisms in hospital and community strainsRoque-Afonso, A. M. / Ly, T. D. / Fé / rey, M. P. / Dussaix, E. et al. | 2006
-
479 Significance of HDV-RNA and HBsAg levels in delta hepatitis: First data of the Hep-Net/international HDV intervention trialZachou, K. / Yurdaydin, C. / Dienes, H. E. / Dalekos, G. N. / Erhardt, A. / Cakaloglu, Y. / Degertekin, H. / Gurel, S. / Zeuzem, S. / Bozkaya, H. et al. | 2006
-
497 Modeling clinical benefits of suppressing viral replication in HBeAg-negative chronic hepatitis B (CHB) patients: A number-needed-to-treat (NNT) analysis of entecavir and adefovirIloeje, U. H. / Yuan, Y. / Klesczewski, K. / Joel Hay, J. et al. | 2006
-
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analoguesPersico, M. / Persico, E. / De Renzog, A. / La Mura, V. / Masarone, M. / Carrino, E. / Morante, A. / Torella, R. et al. | 2006
-
529 Real-time elastography for non-invasive assessment of liver fibrosis in chronic viral hepatitisFriedrich-Rust, M. / Ong, M. E. / Herrmann, E. / Driesi, V. / Samaras, P. / Rembereer, K. / Zeuzem, S. / Sarrazin, C. et al. | 2006
-
633 HLA disparity is associated with ulcerative colitis course after transplantation for PSCCholongitas, E. / Papatheodoridis, G. V. / Zappoli, P. / Giannakopoulos, A. / Patch, D. / Burroughs, A. K. et al. | 2006
-
729 New markers for different rat liver fibrogenic cellsBosselut, N. / Cadoret, A. / Bruneel, A. / Rey, C. / Haddad, I. / Vinh, J. / Vaubourdolle, M. / Housset, C. / Baudin, B. et al. | 2006
-
EASL 2006 Backed Meetings| 2006
-
12 Wild-type HCV NS3 protease re-emerges during follow-up after 14 days of dosing with VX-950 in patients with genotype 1 HCVKieffer, T. / Sarrazin, C. / Bartels, D. / Hanzelka, B. / Mü / h, U. / Welker, M. / Wincheringer, D. / Lin, C. / Purdy, S. et al. | 2006
-
39 Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon/ribavirin (pegifn/RBV) re-treatment in hepatitis patients with prior non-response to PEGIFN/RBV: Week 24 resultsAfdhal, N. / O Brien, C. / Godofsky, E. / Rodriguez-Torres, M. / Pappas, S. C. / Pockros, P. / Lawitz, E. / Bzowej, N. / Rustgi, V. / Sulkowski, M. et al. | 2006
-
54 Cellular binding and entry of hepatitis C virus pseudotypes and virus-like particles requires a different set of cellular co-receptorsHaberstroh, A. / Barth, H. / Schnober, E. K. / Pestka, J. M. / Diepolder, H. M. / Gerlach, J. T. / Patel, A. H. / Blum, H. E. / Cosset, F. / Baumert, T. F. et al. | 2006
-
56 Scavenger receptor class B type i mediates uptake and cross-presentation of hepatitis C virus by human dendritic cellsBarth, H. / Schnober, E. K. / Neumann-Haefelin, C. / Thimme, R. / Blum, H. E. / Baumert, T. F. et al. | 2006
-
66 Endogenous opioids stimulate hsc activity in a paracrine manner during the development of liver fibrosisSvegliati Baroni, G. / De Minicis, S. / Marzioni, M. / Casini, A. / Salzano, R. / Saccomanno, S. / Benedetti, A. et al. | 2006
-
72 Expression of cytoglobin by adeno-associated virus-2 gene transfer inhibits hepatic stellate cell activation and liver fibrosis in toxic and cholestatic models of liver injuryXu, R. / Harrison, P. M. / Chen, M. / Li, L. / Tsui, T. / Fung, P. C. / Cheung, P. / Wang, G. / Diao, Y. / Krissansen, G. W. et al. | 2006
-
90 Hepatic mitochondrial free cholesterol accumulation in the Niemann-pick C diseaseMari, M. / Caballero, F. / Colell, A. / Garcia-Ruiz, C. / Fernandez-Checa, J. C. et al. | 2006
-
92 Prediction of mortality in severe alcoholic hepatitis: Validation of lille model and comparison to other prognostic scoresLouvet, A. / Diaz, E. / Texier, F. / Dharancy, S. / Boitard, J. / Biron, N. / Plane, C. / Deltenre, P. / Hollebecque, A. / Canva, V. et al. | 2006
-
93 Amoxicillin-clavulanate (AC) associated hepatotoxicity: Analysis of a single country large cohort prospectively identifiedAndrade, R. J. / Lucena, M. I. / Pachkoria, K. / Borraz, Y. / Pelaez, G. / Jimé / nez, M. / Rodrigo, L. / Romero-Gomez, M. / Planas, R. et al. | 2006
-
95 Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate dependent and involves AE2 anion exchangerBanales, J. M. / Arenas, F. / Rodriguez-Ortigosa, C. M. / Sá / ez, E. / Uriarte, I. / Doctor, R. B. / Prieto, J. / Medina, J. F. et al. | 2006
-
102 Sphingosine-1-phosphate triggers wound healing via the S1P2 receptor following acute liver injurySerriere-Lanneau, V. / Teixeira-Clerc, F. / Schippers, M. / de Vries, W. / Julien, B. / Tran-Van-Nhieu, J. / Poelstra, K. / Chun, J. / Mallat, A. / Lotersztajn, S. et al. | 2006
-
112 Vascular hypocontractility to angiotensin-II in human and experimental cirrhosis is not related to changes in AT1-receptorexpression, but associated with overexpression of receptor-desensitizing proteinsHennenberg, M. / Trebicka, J. / Hack, G. / Biecker, E. / Schepke, M. / Sauerbruch, T. / Heller, J. et al. | 2006
-
117 The stimulation of purinergic P2Y receptors promotes hepatocyte preconditioning via a SRC and p38 map kinase-dependent mechanismCarini, R. / De Cesaris, M. G. / Alchera, E. / Splendore, R. / Piranda, D. / Baldanzi, G. / Albano, E. et al. | 2006
-
170 Muscle atrophy in advanced cirrhosis: A neglected factor in the evaluation of regional hemodynamicsCaraceni, P. / Dazzani, F. / Salizzoni, E. / Domenicali, M. / Zambruni, A. / Trevisani, F. / Bernardi, M. et al. | 2006
-
172 Heparinase I, II and III modified thromboelastography for the detection of different glycosaminoglycans' effect in cirrhotics with bacterial infectionSenzolo, M. / Cholongitas, E. / Riddell, A. / Coppell, J. / Thalheimer, U. / Burroughs, A. K. et al. | 2006
-
174 Opposite effects of immortalized met murine hepatocytes on cell cycle and cell fate of rat liver hepatic stellate cells and liver myofibroblastsDudas, J. / Novosiadlyy, R. / Aprighano, I. / Saile, B. / Bordoni, V. / Elmaouhoub, A. / Tripodi, M. / Ramadori, G. et al. | 2006
-
182 Protein oxidation in astrocyte of porto-caval shunted rats: Role of oxidative stress in hepatic encephalopathyJover, M. / Diaz-Gó / mez, D. / Fontiveros, E. / Collantes de Terá / n, L. / Parrado, J. / Camacho, I. / Bautista, J. / Romero-Gomez, M. et al. | 2006
-
212 Management of digestive bleeding related to portal hypertension in cirrhotic subjects: Impact of the paris consensus statementCharpigno, C. / Oberti, F. / Bernard, P. / Bartoli, E. / Pauwels, A. / Renard, P. / Cadranel, J. E. / Chabert, B. B. / Barbare, J. C. / Ingrand, I. et al. | 2006
-
211 Synergic action of insulin-like growth factor I (IGF-I) and interferon-α (IFNα) co-administration in experimental cirrhosisCastilla-Cortá / za, I. / Tutau, E. / Puche, J. E. / Garcí / a-Ferná / ndez, M. / Mirpur, E. / Castilla, A. / Quiroga, J. et al. | 2006
-
225 Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy people: A prospective study in potential living related liver donorsKim, K. M. / Park, S. H. / Yu, E. S. / Lee, S. G. / Lim, Y. S. / Lee, H. C. / Chung, Y. H. / Lee, Y. S. / Suh, D. J. et al. | 2006
-
264 Identification of new markers of hepatocellular carcinoma from sera of patients with chronic liver diseases by proteomic pattern discriminationKim, Y. J. / Yoon, J. H. / Lee, H. S. et al. | 2006
-
273 Therapeutic outcomes of radiofrequency ablation (RFA) under general anesthesia for hepatocellular carcinoma (HCC)Saito, A. / Chiba, M. / Haruyama, K. / Nozawa, H. / Shiratori, K. / Katagiri, S. / Katsuragawa, H. / Yamamoto, M. / Takasaki, K. et al. | 2006
-
272 Immunomagnetic isolation and amplification of AFP-specific T-cell populations: A first step towards immunotherapy for hepatocellular carcinomaRichou, C. / Pichard, V. / Geboes, K. / Gaignerie, A. / Masliah, C. / Conchon, S. / Gournay, J. / Ferry, N. et al. | 2006
-
361 Mechanisms of liver regeneration after extensive hepatectomy by plateletsMurata, S. / Matsuo, R. / Ikeda, O. / Ohkohchi, N. et al. | 2006
-
365 The hepatoprotective role of ketanserin in acute cadmium liver injuryPanoutsopoulos, G. I. / Tzirogiannis, K. N. / Papadimas, G. K. / Skaltsas, S. D. / Demonakou, M. D. / Hereti, R. I. / Manta, G. A. / Mykoniatis, M. G. et al. | 2006
-
408 RNA interference against the regulatory 3′-untranslated region efficiently inhibits HCV subgenomic replicon replicationKorf, M. / Meyer, A. / Manns, M. P. / Krü / ger, M. et al. | 2006
-
409 dating the HCV3a epidemic in greece using molecular clock approachesMagiorkinis, G. / Magiorkinis, E. / Paraskevis, D. / Vassilakis, A. / Issaris, C. / Papatheodoridis, G. V. / Tassopoulos, N. C. / Hatzakis, A. et al. | 2006
-
505 Conversion of liver transplant recipients with hepatitis B virus from hepatitis B immune globulin (HBIG) and lamivudine (LAM) to adefovir dipivoxil (ADV) and LAMNeff, G. W. / Zacharias, V. C. / Alonzo, M. / Kenner, N. / Weber, E. / Kaiser, T. E. / Safdar, K. / Rideman, E. / Thomas, M. / Martin, J. et al. | 2006
-
521 Clinical significance of anti-HBc as the only marker of hbv infection in general population. A cohort study with an observational period of up to 12 yearsZacharakis, G. H. / Koskinas, J. / Papoutselis, M. / Tzara, E. / Vafeiadis, N. / Maltezos, E. / Karayiannis, P. / Archimandritis, A. J. / Papoutselis, K. / Kotsiou, S. et al. | 2006
-
551 Hepatitis C virus-associated B cell proliferation: A key role for serum B lymphocyte stimulator (BLYS/BAFF)Sene, D. / Limal, N. / Ghillani-Dalbin, P. / Saadoun, D. / Piette, J. C. / Cacoub, P. et al. | 2006
-
606 Effect of peginterferon alpha-2b and ribavirin on histological lesions in patients with hepatitis C virus (HCV) and HCV/HIV co-infection: An open-label trialSarmento e Castro, R. / Horta, A. / Coelho, H. / Vasconcelos, O. / Mé / ndez, J. / Seabra, J. / Tavares, A. P. / Fortes, O. / Duarte, M. et al. | 2006
-
631 Influence of the predisposing DRB1*08 allele and of the protective HLA-DRB1*11 allele over the expression of primary biliary cirrhosis-specific anti-mitochondrial and anti-nuclear reactivitiesInvernizzi, P. / Bogdanos, D. P. / Bianchi, I. / Meda, E. / Liaskos, C. / Burroughs, A. K. / Zuin, M. / Vergani, D. et al. | 2006
-
634 Assessment of biliary fibrosis by transient elastography in PBC and PSC patientsCorpechot, C. / El Naggar, A. / Poujol-Robert, A. / Ziol, M. / Wendum, D. / Chazouillè / res, O. / de Ledinghen, V. / Dhumeaux, D. / Marcellin, P. et al. | 2006
-
695 Prevalence and risk factors for non-alcoholic fatty liver disease in potential living liver donors in Korea: 589 consecutive biopsies review in single centerLee, J. Y. / Kim, K. M. / Lee, S. G. / Lim, Y. S. / Lee, H. C. / Chung, Y. H. / Lee, Y. S. / Suh, D. J. et al. | 2006
-
727 Serum ALT is not a reliable screening tool for NAFLD in the general populationZelber-Sagi, S. / Lurie, Y. / Nitzan-Kaluski, D. / Halnern, Z. / Oren, R. et al. | 2006
-
738 A one year randomized, placebo-controlled, double-blind trial of rosiglitazone in non-alcoholic steatohepatitis: Results of the flirt pilot trialRatziu, V. / Charlotte, F. / Jacqueminet, S. / Giral, P. / Podevin, P. / Serfaty, L. / Bruckert, E. / Poynard, T. et al. | 2006
-
41st Annual Meeting of EASL| 2006
-
Monothematic Conference: Liver Transplantation for Viral Hepatitis| 2006
-
IntroductionBenhamou, Y. / Salmon, D. et al. | 2006
-
Declarations| 2006
-
Become Part of Our Vision!| 2006
-
EASL School of Hepatology| 2006
-
Editorial Board| 2006
-
42nd Annual Meeting of EASL| 2006
-
IFC/ Editorial Board| 2006
-
1 Multicenter randomized trial of HCV treatment with peginterferon-alpha 2a and ribavirin in liver transplant patients with established recurrent hepatitis C: Interim analysisDuvoux, C. / Samuel, D. / Pageaux, G. / Messner, M. / Wolf, P. / Rostaing, L. / Vanlemmens, C. / Le Treut, Y. P. / Dharancy, S. / Gugenheim, J. et al. | 2006
-
7 Natural history and outcome of acute hepatitis C in patients with end stage renal diseaseKamal, S. / Rasenack, J. / Hafez, A. / Brigel, B. / Chen, J. / Gamal, I. / Shaker, H. / Saad, N. / Afdhal, N. et al. | 2006
-
16 ConA-induced tolerance involves Tregs, kupffer cells, IL-10 and nonresponsiveness in IL-2 producing cellsErhardt, A. / Biburger, M. / Tiegs, G. et al. | 2006
-
51 Optimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patientsZeuzem, S. / Lai, C. L. / Gane, E. / Liaw, Y. F. / Thongsawat, S. / Wang, Y. / Chen, Y. / Heathcote, J. / Rasenack, J. / Bzowej, N. et al. | 2006
-
55 Activation of effector CD8+ T cells in the liver tissue microenvironment in patients with chronic viral hepatitisKennedy, P. T. / Gehring, A. / Patch, D. / Selden, C. / Rees, M. / Williams, R. / Dusheiko, G. / Bertoletti, A. et al. | 2006
-
59 Anti-HCV NS3 serine protease intrabodies act in an unusual inhibition mechanism and have an additive inhibitory effect with IFN-αGal-Tanamy, M. / Zemel, R. / Pupko, O. / Yi, M. / Bachmatov, L. / Denisova, G. / Gershoni, J. M. / Lemon, S. M. / Benhar, I. / Tur-Kaspa, R. et al. | 2006
-
83 Transient elastography to evaluate the severity of hepatitis C recurrence after liver transplantationCarrió / n, J. A. / Navasa, M. / Bosch, J. / Bruguera, M. / Gilabert, R. / Forns, X. et al. | 2006
-
86 Diagnostic value of two new biomarkers (steatotest and NASHtest) for the prediction of steatosis and non-alcoholic steato-hepatitis (NASH)Poynard, T. / Ratziu, V. / Naveau, S. / Charlotte, F. / Imbert-Bismut, F. / Messous, D. / Munteanu, M. / Ngo, Y. / Thabut, D. / Mercadier, A. et al. | 2006
-
97 Glucagon-like peptide-1 (GLP-1) promotes the growth of the biliary tree in the normal and in the cholestatic ratMarzioni, M. / Alpini, G. / Saccomanno, S. / Candelaresi, C. / Glaser, S. / Rychlicki, C. / Francis, H. / Trozzi, L. / Venter, J. / Reichenbach, R. et al. | 2006
-
100 Role of HNF1 inactivation in hepatocellular adenoma lipogenesisRebouissou, S. / Imbeaud, S. / Jeannot, E. / Saric, J. / Balabaud, C. / Bioulac-Sage, P. / Zucman-Rossi, J. et al. | 2006
-
141 Results of liver transplantation in patients with hepatocellular carcinoma. Milan versus expanded criteriaHerrero, J. I. / Armendariz, R. / Sangro, B. / Quiroga, J. / Inarrairaegui, M. / Pardo, F. / Rotellar, F. / Prieto, J. et al. | 2006
-
154 Diagnostic and predictive indexes in patients with fulminant and chronic decompensated Wilson's diseasePetrasek, J. / Trunecka, P. / Jirsa, M. / Sperl, J. / Drastich, P. / Kozak, L. / Spicak, J. et al. | 2006
-
173 Nitric oxide modulates hepatic glutathione metabolism and antioxidant defense in endotoxemic micePayabvash, S. / Ghahremani, M. H. / Mandegary, A. / Shafaroodi, H. / Amanlou, M. / Dehpour, A. R. et al. | 2006
-
198 Albumin and polygeline plus albumin for preventing paracentesis-induced circulatory dysfunction: A randomized controlled trial in refractory ascites. An interim reportTringali, A. / Pinzello, G. B. / Alberti, A. / Belli, L. / Zavaglia, C. et al. | 2006
-
202 Predictors of early rebleeding following endoscopic control of variceal bleedingAbdelsameea, E. / Omar, N. / Waked, I. / Saleh, S. M. et al. | 2006
-
228 Budd-chiari syndrome (BCS) and heparin induced thrombocytopenia (HIT)Plessier, A. / Consigny, Y. / Rautou, P. E. / Boucari, R. / Bezeaud, A. / Boudaoud, L. / Kiladjian, J. J. / Brumpt, C. / Saada, V. / Condat, B. et al. | 2006
-
245 Comparative proteomic analysis of hepatocellular carcinomas on non-fibrotic liver and hepatocellular adenomasBralet, M. P. / Dos Santos, A. / Sarg, S. / Thiers, V. / Bré / chot, C. / Samuel, D. / Guettier, C. / Demaugre, E. et al. | 2006
-
247 Efficacy of hepatitis b virus vaccination on the reduction of hepatocellular carcinoma incidence: Post national program surveillanceChien, Y. C. / Jan, C. E. / Kuo, H. S. / Chen, C. J. et al. | 2006